Document And Entity Information
Document And Entity Information - shares | 3 Months Ended | |
Mar. 31, 2019 | May 14, 2019 | |
Document Information [Line Items] | ||
Entity Registrant Name | OMNICOMM SYSTEMS INC | |
Entity Central Index Key | 0001034592 | |
Trading Symbol | omcm | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Current Reporting Status | Yes | |
Entity Emerging Growth Company | false | |
Entity Small Business | true | |
Entity Common Stock, Shares Outstanding (in shares) | 159,128,341 | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2019 | |
Document Fiscal Year Focus | 2019 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) | Mar. 31, 2019 | Dec. 31, 2018 |
CURRENT ASSETS | ||
Cash | $ 1,351,916 | $ 1,440,524 |
Accounts receivable, net of allowance for doubtful accounts of $152,867 and $176,220, respectively | 3,989,881 | 6,175,277 |
Prepaid expenses | 261,741 | 384,212 |
Other current assets | 1,633 | 5,204 |
Total current assets | 5,605,171 | 8,005,217 |
Property and equipment, net | 1,500,338 | 1,360,315 |
Intangible assets, net | 643,135 | 730,835 |
Right-of-use assets | 1,569,465 | 0 |
Other assets | 89,088 | 131,847 |
TOTAL ASSETS | 9,407,197 | 10,228,214 |
CURRENT LIABILITIES | ||
Accounts payable and accrued expenses | 1,230,092 | 2,070,158 |
Deferred revenue, current portion | 5,302,370 | 6,457,319 |
Finance lease liability, current portion | 116,728 | 115,761 |
Current lease liability | 598,108 | 0 |
Total current liabilities | 9,759,412 | 10,638,476 |
LONG TERM LIABILITIES | ||
Line of credit, long term | 2,500,000 | 2,900,000 |
Notes payable, long term, net of current portion, net of discount of $98,548 and $123,184, respectively | 458,952 | 434,316 |
Convertible notes payable, related parties, long term, net of current portion | 5,770,000 | 5,770,000 |
Convertible notes payable, long term, net of current portion | 200,000 | 200,000 |
Deferred revenue, long term, net of current portion | 1,912,260 | 1,794,237 |
Finance lease liability, long term, net of current portion | 143,757 | 175,089 |
Non-current lease liability | 971,357 | 0 |
TOTAL LIABILITIES | 21,715,738 | 21,912,118 |
COMMITMENTS AND CONTINGENCIES (See Note 11) | ||
SHAREHOLDERS' (DEFICIT) | ||
Common stock, 500,000,000 shares authorized, 158,278,341 and 155,368,647 issued and outstanding, respectively, at $0.001 par value | 158,280 | 155,370 |
Additional paid in capital - preferred | 999,750 | 999,750 |
Additional paid in capital - common | 56,877,493 | 56,233,085 |
Accumulated other comprehensive (loss) | (441,935) | (436,505) |
Accumulated (deficit) | (69,902,379) | (68,635,854) |
TOTAL SHAREHOLDERS' (DEFICIT) | (12,308,541) | (11,683,904) |
TOTAL LIABILITIES AND SHAREHOLDERS' (DEFICIT) | 9,407,197 | 10,228,214 |
Series A Preferred Stock [Member] | ||
SHAREHOLDERS' (DEFICIT) | ||
Preferred stock | 0 | 0 |
Series B Preferred Stock [Member] | ||
SHAREHOLDERS' (DEFICIT) | ||
Preferred stock | 0 | 0 |
Series C Preferred Stock [Member] | ||
SHAREHOLDERS' (DEFICIT) | ||
Preferred stock | 0 | 0 |
Series D Preferred Stock [Member] | ||
SHAREHOLDERS' (DEFICIT) | ||
Preferred stock | 250 | 250 |
Conversion Feature Liability Related Parties [Member] | ||
CURRENT LIABILITIES | ||
Derivative liabilities, current | 862,083 | 670,634 |
Conversion Feature Liability [Member] | ||
CURRENT LIABILITIES | ||
Derivative liabilities, current | 45,415 | 35,705 |
Warrant Liability Related Parties [Member] | ||
CURRENT LIABILITIES | ||
Derivative liabilities, current | 750,625 | 601,781 |
Warrant Liability [Member] | ||
CURRENT LIABILITIES | ||
Derivative liabilities, current | $ 853,991 | $ 687,118 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) | Mar. 31, 2019 | Dec. 31, 2018 |
Allowance for doubtful accounts | $ 152,867 | $ 176,220 |
Notes payable discount | ||
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 10,000,000 | 10,000,000 |
Preferred stock, shares undesignated | $ 3,772,500 | $ 3,772,500 |
Common stock, shares authorized (in shares) | 500,000,000 | 500,000,000 |
Common stock, shares issued (in shares) | 158,278,341 | 155,368,647 |
Common stock, shares outstanding (in shares) | 158,278,341 | 155,368,647 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Series A Preferred Stock [Member] | ||
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 5,000,000 | 5,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Preferred stock, liquidation preference | $ 0 | $ 0 |
Series B Preferred Stock [Member] | ||
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 230,000 | 230,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Preferred stock, liquidation preference | $ 0 | $ 0 |
Series C Preferred Stock [Member] | ||
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 747,500 | 747,500 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Preferred stock, liquidation preference | $ 0 | $ 0 |
Series D Preferred Stock [Member] | ||
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 250,000 | 250,000 |
Preferred stock, shares issued (in shares) | 250,000 | 250,000 |
Preferred stock, shares outstanding (in shares) | 250,000 | 250,000 |
Notes Payable, Other Payables [Member] | ||
Notes payable discount | $ 98,548 | $ 123,184 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Revenues | $ 5,534,298 | $ 7,040,369 |
Reimbursable revenues | 181,521 | 150,103 |
Total revenues | 5,715,819 | 7,190,472 |
Cost of goods sold | 1,054,681 | 1,153,625 |
Reimbursable expenses-cost of goods sold | 69,219 | 57,876 |
Total cost of goods sold | 1,123,900 | 1,211,501 |
Gross margin | 4,591,919 | 5,978,971 |
Operating expenses | ||
Salaries, benefits and related taxes | 3,662,432 | 3,659,340 |
Rent and occupancy expenses | 311,799 | 289,334 |
Consulting services | 50,827 | 125,536 |
Legal and professional fees | 131,763 | 221,252 |
Travel | 148,562 | 200,396 |
Telephone and internet | 50,634 | 29,683 |
Selling, general and administrative | 440,533 | 409,756 |
Bad debt expense | (23,353) | (3,387) |
Depreciation expense | 128,800 | 77,776 |
Amortization expense | 87,700 | 64,149 |
Total operating expenses | 4,989,697 | 5,073,835 |
Operating income/(loss) | (397,778) | 905,136 |
Other income/(expense) | ||
Interest expense, related parties | (190,109) | (225,418) |
Interest expense | (79,270) | (90,943) |
Interest income | 4 | 5 |
Change in derivative liabilities | (583,657) | 28,416 |
Transaction gain/(loss) | (15,726) | (22,678) |
Income/(loss) before income taxes | (1,266,536) | 594,518 |
Income tax (expense) | 11 | (1,035) |
Net income/(loss) attributable to common stockholders | $ (1,266,525) | $ 593,483 |
Net income/(loss) per share | ||
Basic (in dollars per share) | $ (0.01) | $ 0 |
Diluted (in dollars per share) | $ (0.01) | $ 0 |
Weighted average number of shares outstanding | ||
Basic (in shares) | 157,341,946 | 149,653,916 |
Diluted (in shares) | 157,341,946 | 152,693,666 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Comprehensive Income/(Loss) (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Net income/(loss) attributable to common stockholders | $ (1,266,525) | $ 593,483 |
Other comprehensive income/(loss) | ||
Change in foreign currency translation adjustment | (5,430) | 1,287 |
Other comprehensive income/(loss) | (5,430) | 1,287 |
Comprehensive income/(loss) | $ (1,271,955) | $ 594,770 |
Condensed Consolidated Statem_3
Condensed Consolidated Statement of Shareholders' (Deficit) (Unaudited) - USD ($) | Series D Preferred Stock [Member]Preferred Stock [Member] | Additional Paid In Capital Preferred [Member] | Common Stock [Member] | Additional Paid In Capital Common [Member] | Retained Earnings [Member] | AOCI Attributable to Parent [Member] | Total |
Balance (in shares) at Dec. 31, 2017 | 250,000 | 148,542,805 | |||||
Balance at Dec. 31, 2017 | $ 250 | $ 999,750 | $ 148,544 | $ 54,379,454 | $ (72,323,819) | $ (397,237) | $ (17,193,058) |
Employee stock option expense | 56,526 | 56,526 | |||||
Foreign currency translation adjustment | 1,287 | 1,287 | |||||
Net income/(loss) | $ 0 | 0 | $ 0 | 0 | 593,483 | 0 | 593,483 |
Balance (in shares) at Mar. 31, 2018 | 250,000 | 150,209,472 | |||||
Balance at Mar. 31, 2018 | $ 250 | 999,750 | $ 150,211 | 54,934,313 | (71,730,336) | (395,950) | (16,041,762) |
Issuance of common stock, purchase of Acuity (in shares) | 1,666,667 | ||||||
Issuance of common stock, purchase of Acuity | $ 1,667 | 498,333 | 500,000 | ||||
Balance (in shares) at Dec. 31, 2017 | 250,000 | 148,542,805 | |||||
Balance at Dec. 31, 2017 | $ 250 | 999,750 | $ 148,544 | 54,379,454 | (72,323,819) | (397,237) | $ (17,193,058) |
Issuance of common stock, stock option exercise (in shares) | 300,000 | ||||||
Balance (in shares) at Dec. 31, 2018 | 250,000 | 155,368,647 | |||||
Balance at Dec. 31, 2018 | $ 250 | 999,750 | $ 155,370 | 56,233,085 | (68,635,854) | (436,505) | $ (11,683,904) |
Employee stock option expense | 52,927 | 52,927 | |||||
Foreign currency translation adjustment | (5,430) | (5,430) | |||||
Restricted stock issuance/forfeiture (in shares) | 900,000 | ||||||
Restricted stock issuance/forfeiture | $ 900 | 76,710 | $ 77,610 | ||||
Issuance of common stock, stock option exercise (in shares) | 1,800,000 | 0 | |||||
Issuance of common stock, stock option exercise | $ 1,800 | 448,200 | $ 450,000 | ||||
Cashless issuance of common stock, warrant exercise (in shares) | 209,694 | ||||||
Cashless issuance of common stock, warrant exercise | $ 210 | 66,571 | 66,781 | ||||
Net income/(loss) | $ 0 | 0 | $ 0 | 0 | (1,266,525) | 0 | (1,266,525) |
Balance (in shares) at Mar. 31, 2019 | 250,000 | 158,278,341 | |||||
Balance at Mar. 31, 2019 | $ 250 | $ 999,750 | $ 158,280 | $ 56,877,493 | $ (69,902,379) | $ (441,935) | $ (12,308,541) |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2018 | |
CASH FLOWS FROM OPERATING ACTIVITIES | |||
Net income/(loss) | $ (1,266,525) | $ 593,483 | |
Adjustment to reconcile net income/(loss) to net cash provided by/(used in) operating activities | |||
Change in derivative liabilities | 583,657 | (28,416) | |
Interest expense from derivative instruments | 24,637 | 54,518 | |
Employee stock compensation | 130,537 | 56,526 | |
Provision for doubtful accounts | (23,353) | (3,387) | $ 41,782 |
Depreciation and amortization | 216,500 | 141,925 | |
Operating lease right-of-use assets | 160,165 | 0 | |
Changes in operating assets and liabilities | |||
Accounts receivable | 2,208,749 | 1,502,206 | |
Prepaid expenses | 122,471 | 29,547 | |
Other current assets | 3,571 | (9,271) | |
Other assets | 42,759 | (20,977) | |
Accounts payable and accrued expenses | (840,066) | (1,024,533) | |
Operating lease liability | (160,165) | 0 | |
Patent settlement liability | 0 | (112,500) | |
Deferred revenue | (1,036,926) | (2,282,127) | |
Net cash provided by/(used in) operating activities | 166,011 | (1,103,006) | |
CASH FLOWS FROM INVESTING ACTIVITIES | |||
Purchase of property and equipment | (270,711) | (92,794) | |
Purchase of Acuity software | 0 | (552,403) | |
Net cash (used in) investing activities | (270,711) | (645,197) | |
CASH FLOWS FROM FINANCING ACTIVITIES | |||
Proceeds/(repayments) from revolving line of credit | (400,000) | 1,750,000 | |
Proceeds from exercise of warrants | 450,000 | 0 | |
Principal repayment of finance lease obligation | (30,365) | 0 | |
Net cash provided by/(used in) financing activities | 19,635 | 1,750,000 | |
Effect of exchange rate changes on fixed and intangible assets | 1,887 | (3,898) | |
Effect of exchange rate changes on cash and cash equivalents | (5,430) | 1,287 | |
Net increase/(decrease) in cash and cash equivalents | (88,608) | (814) | |
Cash and cash equivalents at beginning of period | 1,440,524 | 1,176,551 | 1,176,551 |
Cash and cash equivalents at end of period | 1,351,916 | 1,175,737 | $ 1,440,524 |
Supplemental disclosures of cash flow information: | |||
Income taxes | 75,041 | 1,035 | |
Interest | 245,256 | 254,092 | |
Non-cash transactions: | |||
Restricted stock issuance/(forfeiture) | 77,610 | 0 | |
Common stock issued for the purchase of Acuity software | 0 | 500,000 | |
Reclassification of warrant feature liability associated with warrant exercise | 66,781 | 0 | |
Operating lease right of use assets and operating lease liability upon adoption of ASU 2016-02, Leases (Topic 842) | $ 1,729,630 | $ 0 |
Note 1 - Organization and Natur
Note 1 - Organization and Nature of Operations | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Nature of Operations [Text Block] | NOTE 1: ORGANIZATION AND NATURE OF OPERATIONS OmniComm Systems, Inc. (“OmniComm” or the “Company”) is a healthcare technology company that provides web-based electronic data capture (“EDC”) and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations (“CROs”) and other clinical trial sponsors principally located in the United States, Europe and East Asia. Our proprietary EDC and eClinical software applications: TrialMaster ® ® ® Our ability to compete within the EDC and eClinical industry is predicated on our ability to continue enhancing and broadening the scope of solutions offered through our EDC and eClinical software and services. Our research and product development efforts are focused on developing new and complementary software solutions, as well as enhancing our existing software solutions through the addition of increased functionality. While our main product development efforts are conducted in our Fort Lauderdale, Florida office, we also conduct product development in other parts of the U.S. as well as in Southampton, England and Bengaluru, India. During the three March 31, 2019 March 31, 2018 $1,089,081, 19% $922,304, 13% |
Note 2 - Summary of Significant
Note 2 - Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Significant Accounting Policies [Text Block] | NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION The Company’s accounts include those of all its wholly-owned subsidiaries, which are more fully described in the Company’s 2018 10 UNAUDITED FINANCIAL STATEMENTS The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, pursuant to the rules and regulations of the Securities and Exchange Commission. Pursuant to such rules and regulations, certain financial information and footnote disclosures normally included in the consolidated financial statements have been condensed or omitted. The results for the three March 31, 2019 March 31, 2018 The operating results for the three March 31, 2019 not may December 31, 2019. 10 December 31, 2018. ESTIMATES IN FINANCIAL STATEMENTS The preparation of the unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Significant estimates incorporated in our financial statements include the recorded allowance for doubtful accounts, the estimate of the appropriate amortization period of our intangible assets, the evaluation of whether our intangible assets have suffered any impairment, the allocation of revenues under multiple-element customer contracts, the determination of lease term and lease assets and liabilities, the value of derivatives associated with debt issued by the Company and the valuation of any corresponding discount to the issuance of our debt. Actual results may Reclassifications Certain reclassifications have been made in the 2018 2019 not foreign currency translation The financial statements of the Company’s foreign subsidiaries are translated in accordance with Accounting Standards Codification (“ASC”) 830 30, Foreign Currency Matters—Translation of Financial Statements 830 30" $5,430 $1,287 three March 31, 2019 March 31, 2018, REVENUE RECOGNITION POLICY The Company derives revenues from software licenses and services of its EDC and eClinical products and services which can be purchased on a stand-alone basis. License revenues are derived principally from the sale of term licenses for the following software products offered by the Company: TrialMaster, TrialOne, eClinical Suite and Promasys. Service revenues are derived principally from the Company's delivery of the hosted solutions of its TrialMaster software product, and consulting services and customer support, including training, for all of the Company's products. For revenue from product sales, the Company recognizes revenue in accordance with Financial Accounting Standards Board ("FASB") ASC 606 606" five 606: not no The Company operates in one four Hosted Application Revenues The Company offers its TrialMaster and TrialOne software products as hosted application solutions delivered through a standard web browser, with customer support and training services. The Company's TrialOne and Promasys solutions are primarily deployed on a technology transfer or off-the-shelf basis. To date, hosted applications revenues have been primarily related to TrialMaster. OmniComm announced that it would decommission its eClinical Suite hosting platform effective April 30, 2019 one Revenues resulting from TrialMaster application hosting services consist of three first second third Fees charged for the trial system design, set-up and implementation are amortized and recognized ratably over the estimated hosting period. Work performed outside the original scope of work is contracted for separately as an additional fee and is generally recognized ratably over the remaining term of the hosting period. Fees for the first third second Licensing Revenues The Company's software license revenues are earned from the sale of off-the-shelf software. From time to time a client might require significant modification or customization subsequent to delivery to the customer. The Company generally enters into software term licenses for its EDC and eClinical Software products with its customers for three five 30 45 The Company has sold perpetual licenses for EDC and eClinical Software products in certain situations to existing customers with the option to purchase customer support, and may, Professional Services The Company may not Maintenance Revenues Maintenance includes telephone-based help desk support and software maintenance, including updates to the software through new software version releases. The Company generally bundles customer support with the software license for the entire term of the arrangement. As a result, the Company generally recognizes revenues for both maintenance and software licenses ratably over the term of the software license and support arrangement. The Company allocates the revenues recognized for these arrangements to the different elements based on management's estimate of the relative fair value of each element. The Company generally invoices each of the elements based on separately quoted amounts and thus has a fairly accurate estimate of the relative fair values of each of the invoiced revenue elements. Pass-through Revenue and Expense The Company accounts for pass-through revenue and expense (reimbursable revenue and reimbursable expense) in accordance with Accounting Standards Update ("ASU") 2016 08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), 2016 08” 2016 08 third third The fees associated with each business activity for the three March 31, 2019 March 31, 2018, For the three months ended Revenue activity March 31, 2019 March 31, 2018 Set-up fees $ 811,354 $ 1,208,554 Change orders 218,622 420,080 Maintenance 1,413,243 1,370,091 Software licenses 2,300,130 3,269,400 Professional services 603,731 431,083 Hosting 368,739 491,264 Total $ 5,715,819 $ 7,190,472 COST OF GOODS SOLD Cost of goods sold primarily consists of costs related to hosting, maintaining and supporting the Company’s application suite and delivering professional services and support. These costs include salaries, benefits and bonuses for the Company’s professional services staff. Cost of goods sold also includes outside service provider costs . CASH AND CASH EQUIVALENTS Cash equivalents consist of highly liquid, short-term investments with maturities of 90 ACCOUNTS RECEIVABLE Accounts receivable are judged as to collectability by management and an allowance for bad debts is established as necessary. The allowance is based on an evaluation of the collectability of accounts receivable and prior bad debt experience. The Company had recorded an allowance for uncollectible accounts receivable of $152,867 March 31, 2019 $176,220 December 31, 2018. The following table summarizes activity in the Company's allowance for doubtful accounts for the three March 31, 2019 December 31, 2018. March 31, 2019 December 31, 2018 Beginning of period $ 176,220 $ 149,980 Bad debt expense (23,353 ) 41,782 Write-offs -0- (15,542 ) End of period $ 152,867 $ 176,220 Concentration of Credit Risk Cash and cash equivalents and restricted cash are deposited with major financial institutions and, at times, such balances with any one may March 31, 2019, $932,167 Except as follows, the Company has no March 31, 2019. March 31, 2019, no not One customer accounted for 7% three March 31, 2019 $417,000. 11% three March 31, 2018 $770,000. 10% three March 31, 2019 March 31, 2018 December 31, 2018. Revenues Accounts receivable For the period ended Number of customers Percentage of total revenues Number of customers Percentage of accounts receivable March 31, 2019 -0- 0% 1 10% December 31, 2018 1 13% 1 20% March 31,2018 1 11% 2 20% The table below provides revenues from European customers for the three March 31, 2019 March 31, 2018. European revenues For the three months ended March 31, 2019 March 31, 2018 European revenues % of Total revenues European revenues % of Total revenues $ 1,167,460 20% $ 1,068,475 15% The Company serves its hosting customers from third not third may PROPERTY AND EQUIPMENT Property and equipment are recorded at cost. Additions and betterments are capitalized; maintenance and repairs are expensed as incurred. Depreciation is calculated using the straight-line method over the asset’s estimated useful life, which is 5 3 LEASES The Company accounts for leases in accordance with ASU No. 2016 02, 842 2016 02” not not March 31, 2019. not may With the adoption of Topic 842 January 1, 2019, $1,729,630. no January 1, 2019. 840. ASSET IMPAIRMENT Acquisitions and Intangible Assets We account for acquisitions in accordance with ASC 805, Business Combinations 805” 350, Intangibles- Goodwill and Other 350” The judgments that we make in determining the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact net income in periods following an asset acquisition. We generally use either the income, cost or market approach to aid in our conclusions of such fair values and asset lives. The income approach presumes that the value of an asset can be estimated by the net economic benefit to be received over the life of the asset, discounted to present value. The cost approach presumes that an investor would pay no Long-lived Assets We review long-lived assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not FAIR VALUE MEASUREMENT OmniComm’s capital structure includes the use of warrants and convertible debt features that are classified as derivative financial instruments. Derivative financial instruments are recognized as either assets or liabilities and are measured at fair value under ASC 815, Derivatives and Hedging 815” . 815 no 820, Fair Value Measurements and Disclosures 820” DEFERRED REVENUE Deferred revenue represents cash advances and amounts in accounts receivable as of the balance sheet date received in excess of revenue earned on on-going contracts. Payment terms vary with each contract but may March 31, 2019, $7,214,630 one 6.25 $5,302,370 twelve ADVERTISING Advertising costs are expensed as incurred. Advertising costs were $185,181 $209,790 three March 31, 2019 March 31, 2018, RESEARCH AND PRODUCT DEVELOPMENT EXPENSES Software development costs are expensed as incurred. ASC 985 20, Software Industry Costs of Software to Be Sold, Leased or Marketed 985 20” not 985 20. three March 31, 2019 March 31, 2018 $1,089,081, 19% $922,304, 13% third EQUITY INCENTIVE PLANS The OmniComm Systems, Inc. 2016 “2016 June 16, 2016. 2016 10,000,000 2016 January 1st nine 9 January 1, 2017 January 1, 2025, five 5% 2016 March 31, 2019 11,576,250 2016 The predecessor plan, the OmniComm Systems, Inc. 2009 “2009 July 10, 2009 June 16, 2016 2016 2009 7,500,000 2016 2009 14, The Company accounts for its employee equity incentive plans under 718, Compensation – Stock Compensation 718” 718 EARNINGS PER SHARE The Company accounts for Earnings per Share using ASC 260, Earnings per Share, 260” INCOME TAXES The Company accounts for income taxes in accordance with ASC 740, Income Taxes 740” . 740 Valuation allowances are established, when necessary, to reduce deferred tax assets to the estimated amount to be realized. Income tax expense represents the tax payable for the current period and the change during the period in the deferred tax assets and liabilities. IMPACT OF NEW ACCOUNTING STANDARDS In February 2016, No. 2016 02, 842 2016 02” 2016 02 12 January 1, 2019, 2016 02, 840, not In August 2018, 2018 15, 350 40 350 40 December 15, 2019. Accounting standards-setting organizations frequently issue new or revised accounting rules. We regularly review all new pronouncements to determine their impact, if any, on our financial statements. |
Note 3 - Earnings (Loss) Per Sh
Note 3 - Earnings (Loss) Per Share | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Earnings Per Share [Text Block] | NOTE 3: EARNINGS/(LOSS) PER SHARE Basic earnings/(loss) per share were calculated using the weighted average number of shares outstanding of 157,341,946 149,653,916 three March 31, 2019 March 31, 2018, The outstanding share balance as of March 31, 2019 March 31, 2018, 1,825,000 0 not Antidilutive shares of 33,495,677 three March 31, 2019 26,343,224 three March 31, 2018, March 31, 2019 March 31, 2018, Anti-dilutive security March 31, 2019 March 31, 2018 Employee stock options 2,420,000 1,295,000 Warrants 19,020,000 12,950,000 Convertible notes 11,940,000 11,980,000 Shares issuable for accrued interest 115,677 118,224 Total 33,495,677 26,343,224 The employee stock options are exercisable at prices ranging from $0.17 $0.34 $0.25 $0.60 $0.50 Some of the Company’s convertible debt has an anti-dilutive effect on net earnings/(loss) per share and was not For the three months ended March 31, 2019 March 31, 2018 Income/(loss) Shares Per-share Income/(loss) Shares Per-share numerator denominator amount numerator denominator amount Basic EPS $ (1,266,525 ) 157,341,946 $ (0.01 ) $ 593,483 149,653,916 $ 0.00 Effect of dilutive securities -0- -0- -0- 139 3,039,750 -0- Diluted EPS $ (1,266,525 ) 157,341,946 $ (0.01 ) $ 593,622 152,693,666 $ 0.00 |
Note 4 - Property and Equipment
Note 4 - Property and Equipment, Net | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Property, Plant and Equipment Disclosure [Text Block] | NOTE 4: PROPERTY AND EQUIPMENT, NET Property and equipment consists of the following: March 31, 2019 December 31, 2018 Description Cost Accumulated depreciation Net book value Cost Accumulated depreciation Net book value Estimated useful life (years) Computer & office equipment $ 3,105,515 $ 2,264,773 $ 840,742 $ 3,067,069 $ 2,202,166 $ 864,903 5 Leasehold improvements 138,383 108,926 29,457 136,648 106,362 30,286 5 Computer software 2,653,982 2,051,411 602,571 2,426,339 1,991,842 434,497 3 Office furniture 168,839 141,271 27,568 169,120 138,491 30,629 5 Total $ 6,066,719 $ 4,566,381 $ 1,500,338 $ 5,799,176 $ 4,438,861 $ 1,360,315 Depreciation expense for the three March 31, 2019 $128,800 $77,776 three March 31, 2018. |
Note 5 - Intangible Assets, Net
Note 5 - Intangible Assets, Net | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Intangible Assets Disclosure [Text Block] | NOTE 5: INTANGIBLE ASSETS, NET Intangible assets consist of the following: March 31, 2019 December 31, 2018 Asset Cost Accumulated amortization Net book value Cost Accumulated amortization Net book value Estimated useful life (years) eClinical Suite customer lists $ 1,392,701 $ 1,392,701 $ -0- $ 1,392,701 $ 1,392,701 $ -0- 3 Promasys B.V. customer lists 111,057 111,057 -0- 113,220 113,220 -0- 15 Promasys B.V. software code 72,837 72,837 -0- 72,837 72,837 -0- 5 Promasys B.V. URLs/website 56,090 56,090 -0- 57,182 57,182 -0- 3 Acuity software code 1,052,403 409,268 643,135 1,052,403 321,568 730,835 3 Total $ 2,685,088 $ 2,041,953 $ 643,135 $ 2,688,343 $ 1,957,508 $ 730,835 During the second 2018 $79,634 Amortization expense for the three March 31, 2019 $87,700 $64,149 three March 31, 2018. Remaining amortization expense for the Company’s intangible assets is as follows: Year Amortization 2019 $ 263,101 2020 350,801 2021 29,233 Total $ 643,135 |
Note 6 - Accounts Payable and A
Note 6 - Accounts Payable and Accrued Expenses | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Accounts Payable and Accrued Liabilities Disclosure [Text Block] | NOTE 6: ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts payable and accrued expenses consist of the following: Account March 31, 2019 December 31, 2018 Accounts payable $ 473,266 $ 895,145 Accrued payroll and related costs 541,369 851,530 Other accrued expenses 142,544 250,570 Accrued interest 72,913 72,913 Total accounts payable and accrued expenses $ 1,230,092 $ 2,070,158 |
Note 7 - Line of Credit, Notes
Note 7 - Line of Credit, Notes Payable and Liquidity | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Debt Disclosure [Text Block] | NOTE 7: LINE OF CREDIT, NOTES PAYABLE AND LIQUIDITY On March 18, 2013, $2,000,000 2.0% $9,500 December 18, 2013 $4,000,000. February 3, 2015 $5,000,000. April 7, 2017 April 7, 2020 March 31, 2019, $2,500,000 4.50%. Our primary sources of working capital are funds from operations and borrowings under our revolving Line of Credit. In the event that the Line of Credit is called for any reason, Mr. Wit has pledged to replace the borrowing capacity under the Line of Credit with a promissory note that utilizes the same maturity date and interest rate as the Line of Credit. To satisfy our capital requirements, we may no not may may The following table summarizes the notes payable outstanding as of March 31, 2019. Ending Non related party Related party Origination Maturity Interest principal Long Long date date rate March 31, 2019 Current term Current term 6/30/2016 4/1/2020 10% $ 420,000 $ -0- $ 420,000 $ -0- $ -0- 6/30/2016 4/1/2020 12% 137,500 -0- 137,500 -0- -0- Discount on notes payable -0- (98,548 ) -0- -0- Total $ 557,500 $ -0- $ 458,952 $ -0- $ -0- The following table summarizes the notes payable outstanding as of December 31, 2018. Ending Non related party Related party Origination Maturity Interest principal Long Long date date rate December 31, 2018 Current term Current term 6/30/2016 4/1/2020 10% $ 420,000 $ -0- $ 420,000 $ -0- $ -0- 6/30/2016 4/1/2020 12% 137,500 -0- 137,500 -0- -0- Discount on notes payable -0- (123,184 ) -0- -0- Total $ 557,500 $ -0- $ 434,316 $ -0- $ -0- On February 29, 2016, $450,000 1,800,000 $0.25 April 1, 2019 $450,000. 12% April 1, 2019. December 5, 2016, 1,000,000 August 31, 2017, $50,000 December 27, 2018, $400,000 $400,000 1,600,000 2,000,000 $0.25 The issuance caused us to calculate and record a derivative liability for the warrant liability. The warrants were valued using the Black Scholes option pricing model. A value of $325,689 $124,311. 37 On June 30, 2016, $372,500 1,490,000 $0.25 April 1, 2020 two 12% April 1, 2020. August 31, 2017, $90,000 one December 31, 2018, $145,000 one The issuance caused us to calculate and record a derivative liability for the warrant liability. The warrants were valued using the Black Scholes option pricing model. A value of $246,921 $125,579. 45 On June 30, 2016, $420,000 1,680,000 $0.25 April 1, 2020 two 10% April 1, 2020. The issuance caused us to calculate and record a derivative liability for the warrant liability. The warrants were valued using the Black Scholes option pricing model. A value of $278,408 $141,592. 45 |
Note 8 - Convertible Notes Paya
Note 8 - Convertible Notes Payable | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Convertible Debt Disclosure [Text Block] | NOTE 8: CONVERTIBLE NOTES PAYABLE The following table summarizes the convertible debt outstanding as of March 31, 2019. Carrying amount Date of Maturity Interest Principal at Short term Long term issuance date rate March 31, 2019 Related Non related Related Non related 8/29/2008 4/1/2020 10% $ 1,770,000 $ -0- $ -0- $ 1,770,000 $ -0- 12/16/2008 4/1/2020 12% 4,000,000 -0- -0- 4,000,000 -0- 12/16/2008 4/1/2021 12% 200,000 -0- -0- -0- 200,000 Total $ 5,970,000 $ -0- $ -0- $ 5,770,000 $ 200,000 The following table summarizes the convertible debt outstanding as of December 31, 2018. Carrying amount Date of Maturity Interest Principal at Short term Long term issuance date rate December 31, 2018 Related Non related Related Non related 8/29/2008 4/1/2020 10% $ 1,770,000 $ -0- $ -0- $ 1,770,000 $ -0- 12/16/2008 4/1/2020 12% 4,000,000 -0- -0- 4,000,000 -0- 12/16/2008 4/1/2021 12% 200,000 -0- -0- -0- 200,000 Total $ 5,970,000 $ -0- $ -0- $ 5,770,000 $ 200,000 10% During 1999, 10% $862,500 $119,625 $742,875. 10% June 30, 2004, $1.25 September 30, 2018, $50,000 $96,949. March 31, 2019, $862,500 1,495,179 0 Convertible Debentures August 2008 On August 29, 2008, $2,270,000 4,540,000 four one 10% August 29, 2010. $0.50 On September 30, 2009, two $1,920,000 August 29, 2013 August 29, 2013. On February 22, 2013, $1,770,000 January 1, 2016. January 1, 2016. On February 22, 2013, $150,000 January 1, 2015. January 1, 2015. On April 21, 2014, $150,000 April 1, 2016. April 1, 2016. July 31, 2014 $150,000 On January 31, 2015, $1,770,000 April 1, 2017. April 1, 2017. On June 30, 2015, $150,000 April 1, 2017. April 1, 2017. On June 30, 2016, $1,770,000 April 1, 2020. April 1, 2020. On June 30, 2016, $150,000 April 1, 2018. April 1, 2018. On June 30, 2017, $150,000 April 1, 2019. April 1, 2019. $150,000 June 30, 2018. December 2008 On December 16, 2008, $5,075,000 10,150,000 eleven four 12% December 16, 2010. $0.50 On September 30, 2009, eight $4,980,000 December 16, 2013 December 16, 2013. On February 22, 2013, $4,505,000 $4,475,000 $25,000 $5,000 January 1, 2016. January 1, 2016. On February 27, 2013, $15,000 January 1, 2016. January 1, 2016. On March 6, 2013, $200,000 January 1, 2014. January 1, 2014. On March 12, 2013, $100,000 January 1, 2015. January 1, 2015. In December 2013, two $360,000 $160,000 January 1, 2016. January 1, 2016. July 31, 2014 $160,000 On April 28, 2014, $100,000 April 1, 2016. April 1, 2016. On January 31, 2015, $4,475,000 April 1, 2017. April 1, 2017. November 19, 2015, $420,000 1,680,000 1,680,000 On April 27, 2015, $200,000 April 1, 2018. April 1, 2018. On April 30, 2015, $25,000 April 1, 2018. April 1, 2018. December 14, 2016. On May 1, 2015, $160,000 April 1, 2017. April 1, 2017. On May 1, 2015, $5,000 On May 7, 2015, $15,000 April 1, 2018. April 1, 2018. $15,000 December 14, 2016. On June 30, 2015, $100,000 April 1, 2017. April 1, 2017. On June 30, 2016, $4,055,000 April 1, 2020. April 1, 2020. August 31, 2017, $55,000 On June 30, 2016, $160,000 April 1, 2018. April 1, 2018. $160,000 December 14, 2016. On June 30, 2016, $100,000 April 1, 2020. April 1, 2020. August 31, 2017, $100,000 On June 30, 2017, $200,000 April 1, 2021. April 1, 2021. The principal payments required at maturity under the Company’s outstanding convertible debt at March 31, 2019 Year Amount 2019 $ -0- 2020 5,770,000 2021 200,000 Total $ 5,970,000 |
Note 9 - Fair Value Measurement
Note 9 - Fair Value Measurement | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Fair Value Disclosures [Text Block] | NOTE 9: FAIR VALUE MEASUREMENT The Company measures the fair value of its assets and liabilities under the guidance of ASC 820, Fair Value Measurements and Disclosures 820” 820 not ASC 820 820 ● Level 1 ● Level 2 ● Level 3 no The valuation techniques that may A. Market approach B. Income approach C. Cost approach The Company also adopted the provisions of ASC 825, Financial Instruments 825” 825 may not The Company’s financial assets or liabilities subject to ASC 820 March 31, 2019 2008 2009 2016 not not 815, Disclosures about Derivative Instruments and Hedging Activities 8 Following is a description of the valuation methodologies used to determine the fair value of the Company’s financial liabilities including the general classification of such instruments pursuant to the valuation hierarchy. A summary, as of March 31, 2019, Fair value at Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs Derivatives: (1) (2) March 31, 2019 (Level 1) (Level 2) (Level 3) Conversion feature liability $ 907,498 $ -0- $ -0- $ 907,498 Warrant liability 1,604,616 -0- -0- 1,604,616 Total of derivative liabilities $ 2,512,114 $ -0- $ -0- $ 2,512,114 ( 1 March 31, 2019. ( 2 Significant valuation assumptions for derivative instruments at March 31, 2019 Risk free interest rate 2.55% to 2.55% Dividend yield 0.00% Expected volatility 88.4% to 95.4% Expected life (range in years) Conversion feature liability 1.01 to 2.01 Warrant liability 0.00 to 2.01 A summary, as of December 31, 2018, s Fair value at Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs Derivatives: (1) (2) December 31, 2018 (Level 1) (Level 2) (Level 3) Conversion feature liability $ 706,339 $ -0- $ -0- $ 706,339 Warrant liability 1,288,899 -0- -0- 1,288,899 Total of derivative liabilities $ 1,995,238 $ -0- $ -0- $ 1,995,238 ( 1 December 31, 2018. ( 2 Significant valuation assumptions for derivative instruments at December 31, 2018 Risk free interest rate 2.70% to 2.70% Dividend yield 0.00% Expected volatility 92.2% to 97.0% Expected life (range in years) Conversion feature liability 1.25 to 2.25 Warrant liability 0.00 to 2.25 A summary, as of March 31, 2019, Carrying amount Carrying amount Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs Acquired assets (1) December 31, 2018 March 31, 2019 (Level 1) (Level 2) (Level 3) Promasys B.V. customer list (2) (3) $ -0- $ -0- $ -0- $ -0- $ 136,253 Promasys B.V. software code (2) -0- -0- -0- -0- 72,943 Acuity software code (4) $ 730,835 643,135 -0- -0- 1,052,403 Total $ 730,835 $ 643,135 $ -0- $ -0- $ 1,261,599 ( 1 ( 2 not ( 3 second 2018 $79,634 ( 4 not A summary, as of December 31, 2018, Carrying amount Carrying amount Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs Acquired assets (1) December 31, 2017 December 31, 2018 (Level 1) (Level 2) (Level 3) Promasys B.V. customer list (2) (3) $ 85,786 $ -0- $ -0- $ -0- $ 136,253 Promasys B.V. software code (2) 12,139 -0- -0- -0- 72,943 Acuity software code (4) -0- 730,835 -0- -0- 1,052,403 Total $ 97,925 $ 730,835 $ -0- $ -0- $ 1,261,599 ( 1 ( 2 not ( 3 second 2018 $79,634 ( 4 not Other identifiable intangible assets, which are subject to amortization, are being amortized using the straight-line method over their estimated useful lives ranging from 3 15 360, Property, Plant and Equipment may not The table below presents the unrealized gains/(losses) for the three March 31, 2019 March 31, 2018. Other income/(expense) For the three months ended March 31, 2019 March 31, 2018 The net amount of gains/(losses) for the period included in earnings attributable to the unrealized and realized gains/(losses) from changes in derivative liabilities at the reporting date $ (583,657 ) $ 28,416 Total unrealized and realized gains/(losses) included in earnings $ (583,657 ) $ 28,416 The tables below set forth a summary of changes in fair value of the Company’s Level 3 three March 31, 2019 December 31, 2018. 3 March 31, 2019 December 31, 2018. The table below presents the Level 3 three March 31, 2019. Level 3 financial liabilities at fair value Net Reclassification purchases, of conversion Balance, issuances feature liability Balance, beginning Net realized Net unrealized and associated with end Derivatives: of period gains/(losses) gains/(losses) settlements convertible debt of period Conversion feature liability $ (706,339 ) $ -0- $ (201,159 ) $ -0- $ -0- $ (907,498 ) Warrant liability (1,288,899 ) -0- (382,498 ) 66,781 -0- (1,604,616 ) Total of derivative liabilities $ (1,995,238 ) $ -0- $ (583,657 ) $ 66,781 $ -0- $ (2,512,114 ) The table below presents the Level 3 December 31, 2018. Level 3 financial liabilities at fair value Net Reclassification purchases, of conversion Balance, issuances feature liability Balance, beginning Net realized Net unrealized and associated with end Derivatives: of year gains/(losses) gains/(losses) settlements convertible debt of year Conversion feature liability $ (1,685,947 ) $ -0- $ 969,108 $ -0- $ 10,500 $ (706,339 ) Warrant liability (3,440,799 ) -0- 2,142,652 9,248 -0- (1,288,899 ) Total of derivative liabilities $ (5,126,746 ) $ -0- $ 3,111,760 $ 9,248 $ 10,500 $ (1,995,238 ) |
Note 10 - Leases
Note 10 - Leases | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Lessee, Leases [Text Block] | NOTE 10: LEASES We adopted ASU 2016 02, 842" January 1, 2019, 2019 Adoption of the new standard resulted in additional operating lease liabilities and lease assets of $1,729,630, January 1, 2019. not Operating right of use asset and operating lease liability are recognized at the lease commencement date. Operating lease liability represents the present value of lease payments not not If we enter into leases that contain multiple components, we identify separate lease components based on whether or not We evaluate arrangements at inception to determine if lease components are included. An arrangement includes a lease component if it identifies an asset and we have control over the asset. For new leases beginning January 1, 2019 Lease assets and liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. Leases with an initial term of 12 not Some of our leases include one may not The Company currently leases office space under operating leases for most of its office locations and has operating leases related to server and network co-location and disaster recovery for its operations. The Company’s Fort Lauderdale, Florida corporate office lease expires in February 2023. March 2021. September 2020. July 2020. May 2023. October 2019. Supplemental balance sheet information related to leases was as follows: Operating Leases Classification March 31, 2019 Right-of-use assets Operating lease assets $ 1,569,465 Current lease liability Current operating lease liability 598,108 Non-current lease liability Long term operating lease liability 971,357 Total lease liabilities $ 1,569,465 Our weighted average lease terms and discount rates are as follows: March 31, 2019 Weighted-average remaining lease term (in years) Operating leases 3.30 Finance leases 2.12 Weighted-average discount rate Operating leases 4.50% Finance leases 6.94% The components of lease cost were as follows: For the three months ended March 31, 2019 Operating lease cost $ 167,888 Variable lease cost (1) 140,910 Total lease cost $ 308,798 (1) Variable lease cost primarily relates to common area maintenance, property taxes and insurance on leased real estate Supplemental disclosures of cash flow information related to leases were as follows: For the three months ended March 31, 2019 Cash paid for operating lease cost $ 167,942 Operating lease assets obtained in exchange for operating lease liabilities $ 1,729,630 March 31, 2019 Year Payments 2019 $ 468,042 2020 476,293 2021 340,478 2022 340,746 Thereafter 76,446 Total undiscounted lease payments 1,702,005 Less: amount representing interest (132,540 ) Present value of lease payments $ 1,569,465 As previously disclosed in our 2018 10 December 31, 2018: Year Payments 2019 $ 655,901 2020 414,973 2021 340,029 2022 340,270 Thereafter 76,243 Total $ 1,827,416 In addition to annual base rental payments, the Company pays for the operating expenses associated with its leased office space and is responsible for any escalation in operating expenses as determined in the leases. Rent expense was $311,799 $289,334 three March 31, 2019 March 31, 2018, The Company currently leases compute five three March 31, 2019 $32,683. March 31, 2019 Year Payments 2019 $ 97,552 2020 130,069 2021 51,898 Total minimum finance lease payments 279,519 Less: amount representing interest (19,034 ) Present value of minimum finance lease payments $ 260,485 |
Note 11 - Commitments and Conti
Note 11 - Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Commitments and Contingencies Disclosure [Text Block] | NOTE 11: COMMITMENTS AND CONTINGENCIES LEGAL PROCEEDINGS From time to time the Company may March 31, 2019, no EMPLOYMENT AGREEMENTS We have employment agreements in place with the following members of our executive management team: Cornelis F. Wit, Executive Chairman Randall G. Smith, Executive Vice Chairman Stephen E. Johnson, Chief Executive Officer and President Thomas E. Vickers, Chief Financial Officer The employment agreements provide, among other things, for participation in employee benefits available to employees and executives. Each of the agreements will renew for successive one may 30 60 may one 1 |
Note 12 - Related Party Transac
Note 12 - Related Party Transactions | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Related Party Transactions Disclosure [Text Block] | NOTE 12: RELATED PARTY TRANSACTIONS As of March 31, 2019, $5,770,000 ● In June 2008, $510,000 August 29, 2008, $510,000 $1,260,000 3,540,000 10% August 29, 2010. $0.50 September 30, 2009, $1,770,000 August 29, 2013 August 29, 2013.On February 22, 2013, $1,770,000 January 1, 2016. January 1, 2016. January 31, 2015, $1,770,000 April 1, 2017. April 1, 2017. June 30, 2016, $1,770,000 April 1, 2020. April 1, 2020. ● In February 2008, $150,000 September 2008 December 2008, $4,200,000 December 16, 2008, $4,350,000 8,700,000 12% December 16, 2010. $0.50 September 30, 2009, $4,350,000 December 16, 2013 December 16, 2013. October 16, 2012, $125,000 December 2008 250,000 February 22, 2013, $4,475,000 January 1, 2016. January 1, 2016. January 31, 2015, $4,475,000 April 1, 2017. April 1, 2017. November 19, 2015, $420,000 1,680,000 1,680,000 June 30, 2016, $4,055,000 April 1, 2020. April 1, 2020. August 31, 2017, $55,000 ● On February 29, 2016, $450,000 1,800,000 $0.25 April 1, 2019 $450,000. 12% April 1, 2019. Aug 31, 2017, $50,000 December 27, 2018, $400,000 $400,000 1,600,000 2,000,000 $0.25 On March 18, 2013, $2,000,000 2.0% $9,500 December 18, 2013, $4,000,000. February 3, 2015, $5,000,000. April 7, 2017, April 7, 2020 March 31, 2019, $2,500,000 4.50%. For the three March 31, 2019 $190,109 $225,418 three March 31, 2018. |
Note 13 - Stockholders' (Defici
Note 13 - Stockholders' (Deficit) | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Stockholders' Equity Note Disclosure [Text Block] | NOTE 13: STOCKHOLDERS’ (DEFICIT) Our authorized capital stock consists of 500,000,000 $0.001 10,000,000 $0.001 5,000,000 5% 230,000 747,500 250,000 As of March 31, 2019 ○ 158,278,341 ○ 19,020,000 ○ 2,420,000 ○ 250,000 ○ $5,970,000 $57,838 11,940,000 115,677 Common Stock Holders of common stock are entitled to one not Holders of common stock have no no may On January 1, 2019 1,800,000 1,800,000 $0.25 $450,000. On March 14, 2019, 225,000 December 31, 2019 75,000 75,000 2019 not $32.5 2019 not $6.5 75,000 2019 not $33.9 2019 not $6.8 1/3 1st April 2020, 2021 2022 $0.28 On March 21, 2019 209,694 1,000,000 $0.25 Preferred Stock Our Board of Directors, without further stockholder approval, may one may ○ dividend and liquidation preferences; ○ voting rights; ○ conversion privileges; and ○ redemption terms. Our Board of Directors may The following table presents the cumulative arrearage of undeclared dividends by class of preferred stock as of March 31, 2019 March 31, 2018, Cumulative arrearage Cumulative arrearage per share March 31, March 31, Series of preferred stock 2019 2018 2019 2018 Series B $ 609,887 $ 609,887 $ 3.05 $ 3.05 Series C 1,472,093 1,472,093 $ 4.37 $ 4.37 Total preferred stock arrearage $ 2,081,980 $ 2,081,980 Warrants Issued in Capital Transactions The following tables summarize all outstanding warrants for the three March 31, 2019 December 31, 2018, March 31, 2019 March 31, 2019 Warrants outstanding Warrants exercisable Weighted average Weighted average Weighted average Range of exercise price Number outstanding remaining contractual life exercise price Number exercisable exercise price $0.25 – $0.60 19,020,000 0.97 $ 0.48 19,020,000 $ 0.48 December 31, 2018 December 31, 2018 Warrants outstanding Warrants exercisable Weighted average Weighted average Weighted average Range of exercise price Number outstanding remaining contractual life exercise price Number exercisable exercise price $0.25 – $0.60 22,020,000 1.06 $ 0.45 22,020,000 $ 0.45 Warrants Balance at December 31, 2017 27,020,000 Issued -0- Exercised (4,000,000 ) Expired/forfeited (1,000,000 ) Balance at December 31, 2018 22,020,000 Issued -0- Exercised (2,800,000 ) Expired/forfeited (200,000 ) Balance at March 31, 2019 19,020,000 Warrants exercisable at March 31, 2019 19,020,000 Weighted average fair value of warrants granted during 2019 n/a Other Comprehensive Income/(Loss) Due to the availability of net operating losses and related deferred tax valuations, there is no Foreign currency translation Accumulated other comprehensive income/(loss) Balance at December 31, 2017 $ (397,237 ) $ (397,237 ) 2018 Activity (39,268 ) (39,268 ) Balance at December 31, 2018 (436,505 ) (436,505 ) 2019 Activity (5,430 ) (5,430 ) Balance at March 31, 2019 $ (441,935 ) $ (441,935 ) |
Note 14 - Equity Incentive Plan
Note 14 - Equity Incentive Plans | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Share-based Payment Arrangement [Text Block] | NOTE 14: EQUITY INCENTIVE PLANS Stock Option Plans Description of 2016 In 2016, 2016 “2016 2016 2016 10,000,000 2016 2016 January 1st nine 9 January 1, 2017 January 1, 2025, five 5% 2016 March 31, 2019 11,576,250 2016 2016 June 29, 2026. The maximum term for any option grant under the 2016 ten 2016 five two first 50% one second second three not 2016 On September 6, 2018, $0.33 225,000 75,000 2018 $30 2018 $6 75,000 2018 $32 2018 $7 75,000 1/3 second third 2018 June 7, 2018. December 31, 2018 not 150,000 225,000 On September 6, 2018, $0.33 200,000 2019 75,000 2018 $30 2018 $6 December 31, 2018 not 75,000 200,000 On March 14, 2019, 225,000 December 31, 2019 75,000 75,000 2019 not $32.5 2019 not $6.5 75,000 2019 not $33.9 2019 not $6.8 1/3 1st April 2020, 2021 2022 $0.28 The total combined restricted stock compensation expense recognized, in the statement of operations, during the quarter ended March 31, 2019 $77,610. As of March 31, 2019, 2,245,000 100,000 1,825,000 2016 March 31, 2019, 7,406,250 2016 Description of 2009 In 2009, 2009 “2009 June 16, 2016, 2009 2016 2009 2009 7,500,000 The maximum term for any option grant under the 2009 ten 2009 five two first 50% one second second three not 2009 As of March 31, 2019, 175,000 3,876,662 2009 March 31, 2019, 0 2009 The following table summarizes the stock option activity for the Company’s equity incentive plans: Number of options Weighted average exercise price Weighted average remaining contractual term Aggregate intrinsic value Outstanding at December 31, 2017 5,275,000 $ 0.26 4.09 $ 130,475 Granted 570,000 0.28 Exercised (300,000 ) 0.21 Forfeited/cancelled/expired (2,975,000 ) 0.25 Outstanding at December 31, 2018 2,570,000 0.28 3.47 $ 16,675 Granted -0- -0- Exercised -0- -0- Forfeited/cancelled/expired (150,000 ) 0.25 Outstanding at March 31, 2019 2,420,000 $ 0.28 3.20 $ 109,000 Vested and exercisable at March 31, 2019 1,547,500 $ 0.26 2.96 $ 94,275 The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company’s closing stock price at quarter-end and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on March 31, 2019. The total number of shares vesting and the fair value of shares vesting for the three March 31, 2019 March 31, 2018, Fair value of options vesting for the period ended Number of options vested Fair value of options vested March 31, 2019 660,000 $ 136,775 March 31, 2018 500,000 $ 99,121 Cash received for stock option exercises for the three March 31, 2019 March 31, 2018 0 0 no three March 31, 2019 March 31, 2018. The following table summarizes information concerning options outstanding at March 31, 2019: Awards breakdown by price range at March 31, 2019 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 150,000 0.68 $ 0.17 150,000 0.68 $ 0.17 0.21 to 0.30 1,545,000 3.28 0.26 1,210,000 3.15 0.26 0.31 to 0.50 725,000 3.57 0.34 187,500 3.57 0.34 0.00 to 0.50 2,420,000 3.20 $ 0.28 1,547,500 2.96 $ 0.26 The following table summarizes information concerning options outstanding at December 31, 2018: Awards breakdown by price range at December 31, 2018 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 150,000 0.93 $ 0.17 150,000 0.93 $ 0.17 0.21 to 0.30 1,695,000 3.54 0.26 550,000 3.15 0.25 0.31 to 0.50 725,000 3.82 0.34 187,500 3.82 0.34 0.00 to 0.50 2,570,000 3.47 $ 0.28 887,500 2.92 $ 0.25 The weighted average fair value (per share) of options granted during the three March 31, 2019 $0.00 no $0.23 three March 31, 2018. Basis for Fair Value Estimate of Share-Based Payments Based on analysis of its historical volatility, the Company expects that the future volatility of its share price is likely to be similar to the historical volatility the Company experienced since the Company’s commercialization activities were initiated during the second 2000. may The Company utilizes the historical data available regarding employee and director exercise activity to calculate an expected life of the options. The table below presents the weighted average expected life in years of options granted under the Plan as described above. The risk-free rate of the stock options is based on the U.S. Treasury yield curve in effect at the time of grant, which corresponds with the expected term of the option granted. Below are the assumptions for the fair value of share-based payments for the three March 31, 2019 December 31, 2018. Stock option assumptions for the period ended Stock option assumptions March 31, 2019 December 31, 2018 Risk-free interest rate 2.48% 2.91% Expected dividend yield 0.0% 0.0% Expected volatility 102.6% 111.0% Expected life of options (in years) 5 5 The following table summarizes weighted average grant date fair value activity for the Company’s incentive stock plans: Weighted average grant date fair value for the period ended March 31, 2019 2018 Stock options granted during the period $ -0- $ 0.23 Stock options vested during the period $ 0.21 $ 0.20 Stock options forfeited during the period $ 0.21 $ 0.19 A summary of the status of the Company’s non-vested shares underlying stock options as of March 31, 2019 three March 31, 2019 Shares underlying stock options Weighted average grant date fair value Nonvested shares at January 1, 2019 1,682,500 $ 0.24 Nonvested shares at March 31, 2019 872,500 $ 0.27 As of March 31, 2019, $195,598 1.9 |
Note 15 - Subsequent Events
Note 15 - Subsequent Events | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Subsequent Events [Text Block] | NOTE 15: SUBSEQUENT EVENTS Subsequent to March 31, 2019 y repaid $1,400,000 Subsequent to March 31, 2019 2014. 50,000 Subsequent to March 31, 2019 800,000 $0.25 800,000 |
Significant Accounting Policies
Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2019 | |
Accounting Policies [Abstract] | |
Basis of Accounting, Policy [Policy Text Block] | BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION The Company’s accounts include those of all its wholly-owned subsidiaries, which are more fully described in the Company’s 2018 10 |
Use of Estimates, Policy [Policy Text Block] | ESTIMATES IN FINANCIAL STATEMENTS The preparation of the unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Significant estimates incorporated in our financial statements include the recorded allowance for doubtful accounts, the estimate of the appropriate amortization period of our intangible assets, the evaluation of whether our intangible assets have suffered any impairment, the allocation of revenues under multiple-element customer contracts, the determination of lease term and lease assets and liabilities, the value of derivatives associated with debt issued by the Company and the valuation of any corresponding discount to the issuance of our debt. Actual results may |
Reclassification, Policy [Policy Text Block] | Reclassifications Certain reclassifications have been made in the 2018 2019 not |
Foreign Currency Transactions and Translations Policy [Policy Text Block] | foreign currency translation The financial statements of the Company’s foreign subsidiaries are translated in accordance with Accounting Standards Codification (“ASC”) 830 30, Foreign Currency Matters—Translation of Financial Statements 830 30" $5,430 $1,287 three March 31, 2019 March 31, 2018, |
Revenue from Contract with Customer [Policy Text Block] | REVENUE RECOGNITION POLICY The Company derives revenues from software licenses and services of its EDC and eClinical products and services which can be purchased on a stand-alone basis. License revenues are derived principally from the sale of term licenses for the following software products offered by the Company: TrialMaster, TrialOne, eClinical Suite and Promasys. Service revenues are derived principally from the Company's delivery of the hosted solutions of its TrialMaster software product, and consulting services and customer support, including training, for all of the Company's products. For revenue from product sales, the Company recognizes revenue in accordance with Financial Accounting Standards Board ("FASB") ASC 606 606" five 606: not no The Company operates in one four Hosted Application Revenues The Company offers its TrialMaster and TrialOne software products as hosted application solutions delivered through a standard web browser, with customer support and training services. The Company's TrialOne and Promasys solutions are primarily deployed on a technology transfer or off-the-shelf basis. To date, hosted applications revenues have been primarily related to TrialMaster. OmniComm announced that it would decommission its eClinical Suite hosting platform effective April 30, 2019 one Revenues resulting from TrialMaster application hosting services consist of three first second third Fees charged for the trial system design, set-up and implementation are amortized and recognized ratably over the estimated hosting period. Work performed outside the original scope of work is contracted for separately as an additional fee and is generally recognized ratably over the remaining term of the hosting period. Fees for the first third second Licensing Revenues The Company's software license revenues are earned from the sale of off-the-shelf software. From time to time a client might require significant modification or customization subsequent to delivery to the customer. The Company generally enters into software term licenses for its EDC and eClinical Software products with its customers for three five 30 45 The Company has sold perpetual licenses for EDC and eClinical Software products in certain situations to existing customers with the option to purchase customer support, and may, Professional Services The Company may not Maintenance Revenues Maintenance includes telephone-based help desk support and software maintenance, including updates to the software through new software version releases. The Company generally bundles customer support with the software license for the entire term of the arrangement. As a result, the Company generally recognizes revenues for both maintenance and software licenses ratably over the term of the software license and support arrangement. The Company allocates the revenues recognized for these arrangements to the different elements based on management's estimate of the relative fair value of each element. The Company generally invoices each of the elements based on separately quoted amounts and thus has a fairly accurate estimate of the relative fair values of each of the invoiced revenue elements. Pass-through Revenue and Expense The Company accounts for pass-through revenue and expense (reimbursable revenue and reimbursable expense) in accordance with Accounting Standards Update ("ASU") 2016 08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), 2016 08” 2016 08 third third The fees associated with each business activity for the three March 31, 2019 March 31, 2018, For the three months ended Revenue activity March 31, 2019 March 31, 2018 Set-up fees $ 811,354 $ 1,208,554 Change orders 218,622 420,080 Maintenance 1,413,243 1,370,091 Software licenses 2,300,130 3,269,400 Professional services 603,731 431,083 Hosting 368,739 491,264 Total $ 5,715,819 $ 7,190,472 |
Cost of Goods and Service [Policy Text Block] | COST OF GOODS SOLD Cost of goods sold primarily consists of costs related to hosting, maintaining and supporting the Company’s application suite and delivering professional services and support. These costs include salaries, benefits and bonuses for the Company’s professional services staff. Cost of goods sold also includes outside service provider costs . |
Cash and Cash Equivalents, Policy [Policy Text Block] | CASH AND CASH EQUIVALENTS Cash equivalents consist of highly liquid, short-term investments with maturities of 90 |
Receivable [Policy Text Block] | ACCOUNTS RECEIVABLE Accounts receivable are judged as to collectability by management and an allowance for bad debts is established as necessary. The allowance is based on an evaluation of the collectability of accounts receivable and prior bad debt experience. The Company had recorded an allowance for uncollectible accounts receivable of $152,867 March 31, 2019 $176,220 December 31, 2018. The following table summarizes activity in the Company's allowance for doubtful accounts for the three March 31, 2019 December 31, 2018. March 31, 2019 December 31, 2018 Beginning of period $ 176,220 $ 149,980 Bad debt expense (23,353 ) 41,782 Write-offs -0- (15,542 ) End of period $ 152,867 $ 176,220 |
Concentration Risk, Credit Risk, Policy [Policy Text Block] | Concentration of Credit Risk Cash and cash equivalents and restricted cash are deposited with major financial institutions and, at times, such balances with any one may March 31, 2019, $932,167 Except as follows, the Company has no March 31, 2019. March 31, 2019, no not One customer accounted for 7% three March 31, 2019 $417,000. 11% three March 31, 2018 $770,000. 10% three March 31, 2019 March 31, 2018 December 31, 2018. Revenues Accounts receivable For the period ended Number of customers Percentage of total revenues Number of customers Percentage of accounts receivable March 31, 2019 -0- 0% 1 10% December 31, 2018 1 13% 1 20% March 31,2018 1 11% 2 20% The table below provides revenues from European customers for the three March 31, 2019 March 31, 2018. European revenues For the three months ended March 31, 2019 March 31, 2018 European revenues % of Total revenues European revenues % of Total revenues $ 1,167,460 20% $ 1,068,475 15% The Company serves its hosting customers from third not third may |
Property, Plant and Equipment, Policy [Policy Text Block] | PROPERTY AND EQUIPMENT Property and equipment are recorded at cost. Additions and betterments are capitalized; maintenance and repairs are expensed as incurred. Depreciation is calculated using the straight-line method over the asset’s estimated useful life, which is 5 3 |
Lessee, Leases [Policy Text Block] | LEASES The Company accounts for leases in accordance with ASU No. 2016 02, 842 2016 02” not not March 31, 2019. not may With the adoption of Topic 842 January 1, 2019, $1,729,630. no January 1, 2019. 840. |
Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] | ASSET IMPAIRMENT Acquisitions and Intangible Assets We account for acquisitions in accordance with ASC 805, Business Combinations 805” 350, Intangibles- Goodwill and Other 350” The judgments that we make in determining the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact net income in periods following an asset acquisition. We generally use either the income, cost or market approach to aid in our conclusions of such fair values and asset lives. The income approach presumes that the value of an asset can be estimated by the net economic benefit to be received over the life of the asset, discounted to present value. The cost approach presumes that an investor would pay no Long-lived Assets We review long-lived assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not |
Fair Value Measurement, Policy [Policy Text Block] | FAIR VALUE MEASUREMENT OmniComm’s capital structure includes the use of warrants and convertible debt features that are classified as derivative financial instruments. Derivative financial instruments are recognized as either assets or liabilities and are measured at fair value under ASC 815, Derivatives and Hedging 815” . 815 no 820, Fair Value Measurements and Disclosures 820” |
Deferred Revenue [Policy Text Block] | DEFERRED REVENUE Deferred revenue represents cash advances and amounts in accounts receivable as of the balance sheet date received in excess of revenue earned on on-going contracts. Payment terms vary with each contract but may March 31, 2019, $7,214,630 one 6.25 $5,302,370 twelve |
Advertising Cost [Policy Text Block] | ADVERTISING Advertising costs are expensed as incurred. Advertising costs were $185,181 $209,790 three March 31, 2019 March 31, 2018, |
Research, Development, and Computer Software, Policy [Policy Text Block] | RESEARCH AND PRODUCT DEVELOPMENT EXPENSES Software development costs are expensed as incurred. ASC 985 20, Software Industry Costs of Software to Be Sold, Leased or Marketed 985 20” not 985 20. three March 31, 2019 March 31, 2018 $1,089,081, 19% $922,304, 13% third |
Share-based Payment Arrangement [Policy Text Block] | EQUITY INCENTIVE PLANS The OmniComm Systems, Inc. 2016 “2016 June 16, 2016. 2016 10,000,000 2016 January 1st nine 9 January 1, 2017 January 1, 2025, five 5% 2016 March 31, 2019 11,576,250 2016 The predecessor plan, the OmniComm Systems, Inc. 2009 “2009 July 10, 2009 June 16, 2016 2016 2009 7,500,000 2016 2009 14, The Company accounts for its employee equity incentive plans under 718, Compensation – Stock Compensation 718” 718 |
Earnings Per Share, Policy [Policy Text Block] | EARNINGS PER SHARE The Company accounts for Earnings per Share using ASC 260, Earnings per Share, 260” |
Income Tax, Policy [Policy Text Block] | INCOME TAXES The Company accounts for income taxes in accordance with ASC 740, Income Taxes 740” . 740 Valuation allowances are established, when necessary, to reduce deferred tax assets to the estimated amount to be realized. Income tax expense represents the tax payable for the current period and the change during the period in the deferred tax assets and liabilities. |
New Accounting Pronouncements, Policy [Policy Text Block] | IMPACT OF NEW ACCOUNTING STANDARDS In February 2016, No. 2016 02, 842 2016 02” 2016 02 12 January 1, 2019, 2016 02, 840, not In August 2018, 2018 15, 350 40 350 40 December 15, 2019. Accounting standards-setting organizations frequently issue new or revised accounting rules. We regularly review all new pronouncements to determine their impact, if any, on our financial statements. |
Note 2 - Summary of Significa_2
Note 2 - Summary of Significant Accounting Policies (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Notes Tables | |
Disaggregation of Revenue [Table Text Block] | For the three months ended Revenue activity March 31, 2019 March 31, 2018 Set-up fees $ 811,354 $ 1,208,554 Change orders 218,622 420,080 Maintenance 1,413,243 1,370,091 Software licenses 2,300,130 3,269,400 Professional services 603,731 431,083 Hosting 368,739 491,264 Total $ 5,715,819 $ 7,190,472 |
Financing Receivable, Allowance for Credit Loss [Table Text Block] | March 31, 2019 December 31, 2018 Beginning of period $ 176,220 $ 149,980 Bad debt expense (23,353 ) 41,782 Write-offs -0- (15,542 ) End of period $ 152,867 $ 176,220 |
Schedules of Concentration of Risk, by Risk Factor [Table Text Block] | Revenues Accounts receivable For the period ended Number of customers Percentage of total revenues Number of customers Percentage of accounts receivable March 31, 2019 -0- 0% 1 10% December 31, 2018 1 13% 1 20% March 31,2018 1 11% 2 20% |
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block] | European revenues For the three months ended March 31, 2019 March 31, 2018 European revenues % of Total revenues European revenues % of Total revenues $ 1,167,460 20% $ 1,068,475 15% |
Note 3 - Earnings (Loss) Per _2
Note 3 - Earnings (Loss) Per Share (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Notes Tables | |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] | Anti-dilutive security March 31, 2019 March 31, 2018 Employee stock options 2,420,000 1,295,000 Warrants 19,020,000 12,950,000 Convertible notes 11,940,000 11,980,000 Shares issuable for accrued interest 115,677 118,224 Total 33,495,677 26,343,224 |
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] | For the three months ended March 31, 2019 March 31, 2018 Income/(loss) Shares Per-share Income/(loss) Shares Per-share numerator denominator amount numerator denominator amount Basic EPS $ (1,266,525 ) 157,341,946 $ (0.01 ) $ 593,483 149,653,916 $ 0.00 Effect of dilutive securities -0- -0- -0- 139 3,039,750 -0- Diluted EPS $ (1,266,525 ) 157,341,946 $ (0.01 ) $ 593,622 152,693,666 $ 0.00 |
Note 4 - Property and Equipme_2
Note 4 - Property and Equipment, Net (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Notes Tables | |
Property, Plant and Equipment [Table Text Block] | March 31, 2019 December 31, 2018 Description Cost Accumulated depreciation Net book value Cost Accumulated depreciation Net book value Estimated useful life (years) Computer & office equipment $ 3,105,515 $ 2,264,773 $ 840,742 $ 3,067,069 $ 2,202,166 $ 864,903 5 Leasehold improvements 138,383 108,926 29,457 136,648 106,362 30,286 5 Computer software 2,653,982 2,051,411 602,571 2,426,339 1,991,842 434,497 3 Office furniture 168,839 141,271 27,568 169,120 138,491 30,629 5 Total $ 6,066,719 $ 4,566,381 $ 1,500,338 $ 5,799,176 $ 4,438,861 $ 1,360,315 |
Note 5 - Intangible Assets, N_2
Note 5 - Intangible Assets, Net (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Notes Tables | |
Schedule of Finite-Lived Intangible Assets [Table Text Block] | March 31, 2019 December 31, 2018 Asset Cost Accumulated amortization Net book value Cost Accumulated amortization Net book value Estimated useful life (years) eClinical Suite customer lists $ 1,392,701 $ 1,392,701 $ -0- $ 1,392,701 $ 1,392,701 $ -0- 3 Promasys B.V. customer lists 111,057 111,057 -0- 113,220 113,220 -0- 15 Promasys B.V. software code 72,837 72,837 -0- 72,837 72,837 -0- 5 Promasys B.V. URLs/website 56,090 56,090 -0- 57,182 57,182 -0- 3 Acuity software code 1,052,403 409,268 643,135 1,052,403 321,568 730,835 3 Total $ 2,685,088 $ 2,041,953 $ 643,135 $ 2,688,343 $ 1,957,508 $ 730,835 |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] | Year Amortization 2019 $ 263,101 2020 350,801 2021 29,233 Total $ 643,135 |
Note 6 - Accounts Payable and_2
Note 6 - Accounts Payable and Accrued Expenses (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Notes Tables | |
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] | Account March 31, 2019 December 31, 2018 Accounts payable $ 473,266 $ 895,145 Accrued payroll and related costs 541,369 851,530 Other accrued expenses 142,544 250,570 Accrued interest 72,913 72,913 Total accounts payable and accrued expenses $ 1,230,092 $ 2,070,158 |
Note 7 - Line of Credit, Note_2
Note 7 - Line of Credit, Notes Payable and Liquidity (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Notes Tables | |
Schedule of Debt [Table Text Block] | Ending Non related party Related party Origination Maturity Interest principal Long Long date date rate March 31, 2019 Current term Current term 6/30/2016 4/1/2020 10% $ 420,000 $ -0- $ 420,000 $ -0- $ -0- 6/30/2016 4/1/2020 12% 137,500 -0- 137,500 -0- -0- Discount on notes payable -0- (98,548 ) -0- -0- Total $ 557,500 $ -0- $ 458,952 $ -0- $ -0- Ending Non related party Related party Origination Maturity Interest principal Long Long date date rate December 31, 2018 Current term Current term 6/30/2016 4/1/2020 10% $ 420,000 $ -0- $ 420,000 $ -0- $ -0- 6/30/2016 4/1/2020 12% 137,500 -0- 137,500 -0- -0- Discount on notes payable -0- (123,184 ) -0- -0- Total $ 557,500 $ -0- $ 434,316 $ -0- $ -0- |
Note 8 - Convertible Notes Pa_2
Note 8 - Convertible Notes Payable (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Notes Tables | |
Schedule of Maturities of Long-term Debt [Table Text Block] | Year Amount 2019 $ -0- 2020 5,770,000 2021 200,000 Total $ 5,970,000 |
Convertible Debt [Member] | |
Notes Tables | |
Schedule of Long-term Debt Instruments [Table Text Block] | Carrying amount Date of Maturity Interest Principal at Short term Long term issuance date rate March 31, 2019 Related Non related Related Non related 8/29/2008 4/1/2020 10% $ 1,770,000 $ -0- $ -0- $ 1,770,000 $ -0- 12/16/2008 4/1/2020 12% 4,000,000 -0- -0- 4,000,000 -0- 12/16/2008 4/1/2021 12% 200,000 -0- -0- -0- 200,000 Total $ 5,970,000 $ -0- $ -0- $ 5,770,000 $ 200,000 Carrying amount Date of Maturity Interest Principal at Short term Long term issuance date rate December 31, 2018 Related Non related Related Non related 8/29/2008 4/1/2020 10% $ 1,770,000 $ -0- $ -0- $ 1,770,000 $ -0- 12/16/2008 4/1/2020 12% 4,000,000 -0- -0- 4,000,000 -0- 12/16/2008 4/1/2021 12% 200,000 -0- -0- -0- 200,000 Total $ 5,970,000 $ -0- $ -0- $ 5,770,000 $ 200,000 |
Note 9 - Fair Value Measureme_2
Note 9 - Fair Value Measurement (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Notes Tables | |
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] | Fair value at Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs Derivatives: (1) (2) March 31, 2019 (Level 1) (Level 2) (Level 3) Conversion feature liability $ 907,498 $ -0- $ -0- $ 907,498 Warrant liability 1,604,616 -0- -0- 1,604,616 Total of derivative liabilities $ 2,512,114 $ -0- $ -0- $ 2,512,114 Fair value at Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs Derivatives: (1) (2) December 31, 2018 (Level 1) (Level 2) (Level 3) Conversion feature liability $ 706,339 $ -0- $ -0- $ 706,339 Warrant liability 1,288,899 -0- -0- 1,288,899 Total of derivative liabilities $ 1,995,238 $ -0- $ -0- $ 1,995,238 |
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] | Significant valuation assumptions for derivative instruments at March 31, 2019 Risk free interest rate 2.55% to 2.55% Dividend yield 0.00% Expected volatility 88.4% to 95.4% Expected life (range in years) Conversion feature liability 1.01 to 2.01 Warrant liability 0.00 to 2.01 Significant valuation assumptions for derivative instruments at December 31, 2018 Risk free interest rate 2.70% to 2.70% Dividend yield 0.00% Expected volatility 92.2% to 97.0% Expected life (range in years) Conversion feature liability 1.25 to 2.25 Warrant liability 0.00 to 2.25 |
Fair Value Measurements, Nonrecurring [Table Text Block] | Carrying amount Carrying amount Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs Acquired assets (1) December 31, 2018 March 31, 2019 (Level 1) (Level 2) (Level 3) Promasys B.V. customer list (2) (3) $ -0- $ -0- $ -0- $ -0- $ 136,253 Promasys B.V. software code (2) -0- -0- -0- -0- 72,943 Acuity software code (4) $ 730,835 643,135 -0- -0- 1,052,403 Total $ 730,835 $ 643,135 $ -0- $ -0- $ 1,261,599 Carrying amount Carrying amount Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs Acquired assets (1) December 31, 2017 December 31, 2018 (Level 1) (Level 2) (Level 3) Promasys B.V. customer list (2) (3) $ 85,786 $ -0- $ -0- $ -0- $ 136,253 Promasys B.V. software code (2) 12,139 -0- -0- -0- 72,943 Acuity software code (4) -0- 730,835 -0- -0- 1,052,403 Total $ 97,925 $ 730,835 $ -0- $ -0- $ 1,261,599 |
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Table Text Block] | Other income/(expense) For the three months ended March 31, 2019 March 31, 2018 The net amount of gains/(losses) for the period included in earnings attributable to the unrealized and realized gains/(losses) from changes in derivative liabilities at the reporting date $ (583,657 ) $ 28,416 Total unrealized and realized gains/(losses) included in earnings $ (583,657 ) $ 28,416 |
Schedule of Derivative Liabilities at Fair Value [Table Text Block] | Level 3 financial liabilities at fair value Net Reclassification purchases, of conversion Balance, issuances feature liability Balance, beginning Net realized Net unrealized and associated with end Derivatives: of period gains/(losses) gains/(losses) settlements convertible debt of period Conversion feature liability $ (706,339 ) $ -0- $ (201,159 ) $ -0- $ -0- $ (907,498 ) Warrant liability (1,288,899 ) -0- (382,498 ) 66,781 -0- (1,604,616 ) Total of derivative liabilities $ (1,995,238 ) $ -0- $ (583,657 ) $ 66,781 $ -0- $ (2,512,114 ) Level 3 financial liabilities at fair value Net Reclassification purchases, of conversion Balance, issuances feature liability Balance, beginning Net realized Net unrealized and associated with end Derivatives: of year gains/(losses) gains/(losses) settlements convertible debt of year Conversion feature liability $ (1,685,947 ) $ -0- $ 969,108 $ -0- $ 10,500 $ (706,339 ) Warrant liability (3,440,799 ) -0- 2,142,652 9,248 -0- (1,288,899 ) Total of derivative liabilities $ (5,126,746 ) $ -0- $ 3,111,760 $ 9,248 $ 10,500 $ (1,995,238 ) |
Note 10 - Leases (Tables)
Note 10 - Leases (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Notes Tables | |
Lease, Cost [Table Text Block] | Operating Leases Classification March 31, 2019 Right-of-use assets Operating lease assets $ 1,569,465 Current lease liability Current operating lease liability 598,108 Non-current lease liability Long term operating lease liability 971,357 Total lease liabilities $ 1,569,465 March 31, 2019 Weighted-average remaining lease term (in years) Operating leases 3.30 Finance leases 2.12 Weighted-average discount rate Operating leases 4.50% Finance leases 6.94% For the three months ended March 31, 2019 Operating lease cost $ 167,888 Variable lease cost (1) 140,910 Total lease cost $ 308,798 (1) Variable lease cost primarily relates to common area maintenance, property taxes and insurance on leased real estate For the three months ended March 31, 2019 Cash paid for operating lease cost $ 167,942 Operating lease assets obtained in exchange for operating lease liabilities $ 1,729,630 |
Lessee, Operating and Finance Lease, Liability, Maturity [Table Text Block] | Year Payments 2019 $ 468,042 2020 476,293 2021 340,478 2022 340,746 Thereafter 76,446 Total undiscounted lease payments 1,702,005 Less: amount representing interest (132,540 ) Present value of lease payments $ 1,569,465 Year Payments 2019 $ 97,552 2020 130,069 2021 51,898 Total minimum finance lease payments 279,519 Less: amount representing interest (19,034 ) Present value of minimum finance lease payments $ 260,485 |
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] | Year Payments 2019 $ 655,901 2020 414,973 2021 340,029 2022 340,270 Thereafter 76,243 Total $ 1,827,416 |
Note 13 - Stockholders' (Defi_2
Note 13 - Stockholders' (Deficit) (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Notes Tables | |
Schedule Of Dividends In Arrears [Table Text Block] | Cumulative arrearage Cumulative arrearage per share March 31, March 31, Series of preferred stock 2019 2018 2019 2018 Series B $ 609,887 $ 609,887 $ 3.05 $ 3.05 Series C 1,472,093 1,472,093 $ 4.37 $ 4.37 Total preferred stock arrearage $ 2,081,980 $ 2,081,980 |
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] | March 31, 2019 March 31, 2019 Warrants outstanding Warrants exercisable Weighted average Weighted average Weighted average Range of exercise price Number outstanding remaining contractual life exercise price Number exercisable exercise price $0.25 – $0.60 19,020,000 0.97 $ 0.48 19,020,000 $ 0.48 December 31, 2018 December 31, 2018 Warrants outstanding Warrants exercisable Weighted average Weighted average Weighted average Range of exercise price Number outstanding remaining contractual life exercise price Number exercisable exercise price $0.25 – $0.60 22,020,000 1.06 $ 0.45 22,020,000 $ 0.45 |
Share-based Payment Arrangement, Activity [Table Text Block] | Weighted average grant date fair value for the period ended March 31, 2019 2018 Stock options granted during the period $ -0- $ 0.23 Stock options vested during the period $ 0.21 $ 0.20 Stock options forfeited during the period $ 0.21 $ 0.19 |
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] | Foreign currency translation Accumulated other comprehensive income/(loss) Balance at December 31, 2017 $ (397,237 ) $ (397,237 ) 2018 Activity (39,268 ) (39,268 ) Balance at December 31, 2018 (436,505 ) (436,505 ) 2019 Activity (5,430 ) (5,430 ) Balance at March 31, 2019 $ (441,935 ) $ (441,935 ) |
Warrant [Member] | |
Notes Tables | |
Share-based Payment Arrangement, Activity [Table Text Block] | Warrants Balance at December 31, 2017 27,020,000 Issued -0- Exercised (4,000,000 ) Expired/forfeited (1,000,000 ) Balance at December 31, 2018 22,020,000 Issued -0- Exercised (2,800,000 ) Expired/forfeited (200,000 ) Balance at March 31, 2019 19,020,000 Warrants exercisable at March 31, 2019 19,020,000 Weighted average fair value of warrants granted during 2019 n/a |
Note 14 - Equity Incentive Pl_2
Note 14 - Equity Incentive Plans (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Notes Tables | |
Share-based Payment Arrangement, Option, Activity [Table Text Block] | Number of options Weighted average exercise price Weighted average remaining contractual term Aggregate intrinsic value Outstanding at December 31, 2017 5,275,000 $ 0.26 4.09 $ 130,475 Granted 570,000 0.28 Exercised (300,000 ) 0.21 Forfeited/cancelled/expired (2,975,000 ) 0.25 Outstanding at December 31, 2018 2,570,000 0.28 3.47 $ 16,675 Granted -0- -0- Exercised -0- -0- Forfeited/cancelled/expired (150,000 ) 0.25 Outstanding at March 31, 2019 2,420,000 $ 0.28 3.20 $ 109,000 Vested and exercisable at March 31, 2019 1,547,500 $ 0.26 2.96 $ 94,275 |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block] | Fair value of options vesting for the period ended Number of options vested Fair value of options vested March 31, 2019 660,000 $ 136,775 March 31, 2018 500,000 $ 99,121 |
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block] | Awards breakdown by price range at March 31, 2019 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 150,000 0.68 $ 0.17 150,000 0.68 $ 0.17 0.21 to 0.30 1,545,000 3.28 0.26 1,210,000 3.15 0.26 0.31 to 0.50 725,000 3.57 0.34 187,500 3.57 0.34 0.00 to 0.50 2,420,000 3.20 $ 0.28 1,547,500 2.96 $ 0.26 Awards breakdown by price range at December 31, 2018 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 150,000 0.93 $ 0.17 150,000 0.93 $ 0.17 0.21 to 0.30 1,695,000 3.54 0.26 550,000 3.15 0.25 0.31 to 0.50 725,000 3.82 0.34 187,500 3.82 0.34 0.00 to 0.50 2,570,000 3.47 $ 0.28 887,500 2.92 $ 0.25 |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | Stock option assumptions for the period ended Stock option assumptions March 31, 2019 December 31, 2018 Risk-free interest rate 2.48% 2.91% Expected dividend yield 0.0% 0.0% Expected volatility 102.6% 111.0% Expected life of options (in years) 5 5 |
Share-based Payment Arrangement, Activity [Table Text Block] | Weighted average grant date fair value for the period ended March 31, 2019 2018 Stock options granted during the period $ -0- $ 0.23 Stock options vested during the period $ 0.21 $ 0.20 Stock options forfeited during the period $ 0.21 $ 0.19 |
Schedule of Nonvested Share Activity [Table Text Block] | Shares underlying stock options Weighted average grant date fair value Nonvested shares at January 1, 2019 1,682,500 $ 0.24 Nonvested shares at March 31, 2019 872,500 $ 0.27 |
Note 1 - Organization and Nat_2
Note 1 - Organization and Nature of Operations (Details Textual) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Research and Development Expense, Total | $ 1,089,081 | $ 922,304 |
Research and Development Expense, Percent of Revenue | 19.00% | 13.00% |
Note 2 - Summary of Significa_3
Note 2 - Summary of Significant Accounting Policies (Details Textual) - USD ($) | 3 Months Ended | 12 Months Ended | ||||
Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2018 | Jan. 01, 2019 | Jun. 16, 2016 | Jul. 10, 2009 | |
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total | $ (5,430) | $ 1,287 | ||||
Accounts Receivable, Allowance for Credit Loss, Current | 152,867 | $ 176,220 | ||||
Cash, Uninsured Amount | 932,167 | |||||
Revenues, Total | 5,715,819 | 7,190,472 | ||||
Operating Lease, Right-of-Use Asset | 1,569,465 | 0 | ||||
Deferred Revenue, Total | 7,214,630 | |||||
Deferred Revenue, Current, Total | 5,302,370 | $ 6,457,319 | ||||
Advertising Expense | 185,181 | 209,790 | ||||
Research and Development Expense, Total | $ 1,089,081 | $ 922,304 | ||||
Research and Development Expense, Percent of Revenue | 19.00% | 13.00% | ||||
Operating Lease, Liability, Total | $ 1,569,465 | |||||
The 2016 Plan [Member] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 11,576,250 | 10,000,000 | ||||
Common Stock Available for Issuance Increasing Period | 9 years | |||||
Common Stock Available for Issuance, Annual Increase Percent | 5.00% | |||||
Plan 2009 [Member] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 7,500,000 | |||||
Accounting Standards Update 2016-02 [Member] | ||||||
Operating Lease, Right-of-Use Asset | $ 1,729,630 | |||||
Operating Lease, Liability, Total | $ 1,730,907 | |||||
Leasehold Improvements Computers Equipment And Furniture [Member] | ||||||
Property, Plant and Equipment, Useful Life | 5 years | |||||
Software Development [Member] | ||||||
Property, Plant and Equipment, Useful Life | 3 years | |||||
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | ||||||
Concentration Risk, Percentage | 0.00% | 11.00% | 13.00% | |||
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer 1 [Member] | ||||||
Concentration Risk, Percentage | 7.00% | 11.00% | ||||
Revenues, Total | $ 417,000 | $ 770,000 | ||||
Minimum [Member] | ||||||
Term Of Software License | 3 years | |||||
Deferred Revenue, Service Contract Term | 30 days | |||||
Maximum [Member] | ||||||
Term Of Software License | 5 years | |||||
Deferred Revenue, Service Contract Term | 6 years 91 days |
Note 2 - Summary of Significa_4
Note 2 - Summary of Significant Accounting Policies - Revenue by Business Activity (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Revenues, Total | $ 5,715,819 | $ 7,190,472 |
Set Up Fees [Member] | ||
Revenues, Total | 811,354 | 1,208,554 |
Change Orders [Member] | ||
Revenues, Total | 218,622 | 420,080 |
Maintenance 1 [Member] | ||
Revenues, Total | 1,413,243 | 1,370,091 |
Software Licenses [Member] | ||
Revenues, Total | 2,300,130 | 3,269,400 |
Professional Services [Member] | ||
Revenues, Total | 603,731 | 431,083 |
Hosting [Member] | ||
Revenues, Total | $ 368,739 | $ 491,264 |
Note 2 - Summary of Significa_5
Note 2 - Summary of Significant Accounting Policies - Allowance for Doubtful Account Summary (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2018 | |
Beginning of period | $ 176,220 | $ 149,980 | $ 149,980 |
Bad debt expense | (23,353) | $ (3,387) | 41,782 |
Write-offs | 0 | (15,542) | |
End of period | $ 152,867 | $ 176,220 |
Note 2 - Summary of Significa_6
Note 2 - Summary of Significant Accounting Policies - Customer Concentration (Details) - Customer Concentration Risk [Member] | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2018 | |
Revenue Benchmark [Member] | |||
Number of customers | 0 | 1 | 1 |
Concentration Risk, Percentage | 0.00% | 11.00% | 13.00% |
Accounts Receivable [Member] | |||
Number of customers | 1 | 2 | 1 |
Concentration Risk, Percentage | 10.00% | 20.00% | 20.00% |
Note 2 - Summary of Significa_7
Note 2 - Summary of Significant Accounting Policies - Revenue From European Operations (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2018 | |
Revenues | $ 5,715,819 | $ 7,190,472 | |
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | |||
Concentration risk, percentage | 0.00% | 11.00% | 13.00% |
Reportable Geographical Components [Member] | Europe [Member] | |||
Revenues | $ 1,167,460 | $ 1,068,475 | |
Reportable Geographical Components [Member] | Europe [Member] | Customer Concentration Risk [Member] | Revenue Benchmark [Member] | |||
Concentration risk, percentage | 20.00% | 15.00% |
Note 3 - Earnings (Loss) Per _3
Note 3 - Earnings (Loss) Per Share (Details Textual) - $ / shares | 3 Months Ended | ||
Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2018 | |
Weighted Average Number of Shares Outstanding, Basic, Total | 157,341,946 | 149,653,916 | |
Common Stock, Shares, Outstanding, Ending Balance | 158,278,341 | 155,368,647 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 33,495,677 | 26,343,224 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | $ 0.26 | ||
Debt Instrument, Convertible, Conversion Price | 0.50 | ||
Minimum [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | 0.17 | ||
Class of Warrant or Right, Exercise Price of Warrants or Rights | 0.25 | $ 0.25 | |
Maximum [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | 0.34 | ||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.60 | $ 0.60 | |
Restricted Stock [Member] | |||
Common Stock, Shares, Outstanding, Ending Balance | 1,825,000 | 0 |
Note 3 - Earnings (Loss) Per _4
Note 3 - Earnings (Loss) Per Share - Reconciliation of Anti-dilutive Securities (Details) - shares | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Anti-dilutive Security (in shares) | 33,495,677 | 26,343,224 |
Share-based Payment Arrangement, Option [Member] | ||
Anti-dilutive Security (in shares) | 2,420,000 | 1,295,000 |
Warrant [Member] | ||
Anti-dilutive Security (in shares) | 19,020,000 | 12,950,000 |
Convertible Debt Securities [Member] | ||
Anti-dilutive Security (in shares) | 11,940,000 | 11,980,000 |
Shares Issuable For Accrued Interest [Member] | ||
Anti-dilutive Security (in shares) | 115,677 | 118,224 |
Note 3 - Earnings (Loss) Per _5
Note 3 - Earnings (Loss) Per Share - Computation of Diluted Earnings Per Share (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Basic EPS, Income (loss) numerator | $ (1,266,525) | $ 593,483 |
Weighted Average Number of Shares Outstanding, Basic, Total | 157,341,946 | 149,653,916 |
Basic EPS, Per-share amount (in dollars per share) | $ (0.01) | $ 0 |
Effect of dilutive securities, Income (loss) numerator | $ 0 | $ 139 |
Effect of dilutive securities, Shares denominator (in shares) | 0 | 3,039,750 |
Effect of dilutive securities, Per-share amount (in dollars per share) | $ 0 | $ 0 |
Diluted EPS, Income (loss) numerator | $ (1,266,525) | $ 593,622 |
Diluted EPS, Shares denominator (in shares) | 157,341,946 | 152,693,666 |
Diluted EPS, Per-share amount (in dollars per share) | $ (0.01) | $ 0 |
Note 4 - Property and Equipme_3
Note 4 - Property and Equipment, Net (Details Textual) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Depreciation, Total | $ 128,800 | $ 77,776 |
Note 4 - Property and Equipme_4
Note 4 - Property and Equipment, Net - Property and Equipment (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Dec. 31, 2018 | |
Cost | $ 6,066,719 | $ 5,799,176 |
Accumulated Depreciation | 4,566,381 | 4,438,861 |
Net Book Value | 1,500,338 | 1,360,315 |
Computer And Office Equipment [Member] | ||
Cost | 3,105,515 | 3,067,069 |
Accumulated Depreciation | 2,264,773 | 2,202,166 |
Net Book Value | $ 840,742 | 864,903 |
Estimated Useful Lives (Year) | 5 years | |
Leasehold Improvements [Member] | ||
Cost | $ 138,383 | 136,648 |
Accumulated Depreciation | 108,926 | 106,362 |
Net Book Value | $ 29,457 | 30,286 |
Estimated Useful Lives (Year) | 5 years | |
Software and Software Development Costs [Member] | ||
Cost | $ 2,653,982 | 2,426,339 |
Accumulated Depreciation | 2,051,411 | 1,991,842 |
Net Book Value | $ 602,571 | 434,497 |
Estimated Useful Lives (Year) | 3 years | |
Furniture and Fixtures [Member] | ||
Cost | $ 168,839 | 169,120 |
Accumulated Depreciation | 141,271 | 138,491 |
Net Book Value | $ 27,568 | $ 30,629 |
Estimated Useful Lives (Year) | 5 years |
Note 5 - Intangible Assets, N_3
Note 5 - Intangible Assets, Net (Details Textual) - USD ($) | 3 Months Ended | ||
Mar. 31, 2019 | Jun. 30, 2018 | Mar. 31, 2018 | |
Impairment of Intangible Assets, Finite-lived | $ 79,634 | ||
Amortization of Intangible Assets, Total | $ 87,700 | $ 64,149 |
Note 5 - Intangible Assets, N_4
Note 5 - Intangible Assets, Net - Intangible Assets (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Dec. 31, 2018 | |
Cost | $ 2,685,088 | $ 2,688,343 |
Accumulated Amortization | 2,041,953 | 1,957,508 |
Net Book Value | 643,135 | 730,835 |
eClinical Customer List [Member] | ||
Cost | 1,392,701 | 1,392,701 |
Accumulated Amortization | 1,392,701 | 1,392,701 |
Net Book Value | $ 0 | 0 |
Finite-Lived Intangible Asset, Useful Life | 3 years | |
Promasys B.V. Customer List [Member] | ||
Cost | $ 111,057 | 113,220 |
Accumulated Amortization | 111,057 | 113,220 |
Net Book Value | $ 0 | 0 |
Finite-Lived Intangible Asset, Useful Life | 15 years | |
Promasys B.V. Software Code [Member] | ||
Cost | $ 72,837 | 72,837 |
Accumulated Amortization | 72,837 | 72,837 |
Net Book Value | $ 0 | 0 |
Finite-Lived Intangible Asset, Useful Life | 5 years | |
Promasys B.V. URLs/Website [Member] | ||
Cost | $ 56,090 | 57,182 |
Accumulated Amortization | 56,090 | 57,182 |
Net Book Value | $ 0 | 0 |
Finite-Lived Intangible Asset, Useful Life | 3 years | |
Acuity Software Code [Member] | ||
Cost | $ 1,052,403 | 1,052,403 |
Accumulated Amortization | 409,268 | 321,568 |
Net Book Value | $ 643,135 | $ 730,835 |
Finite-Lived Intangible Asset, Useful Life | 3 years |
Note 5 - Intangible Assets, N_5
Note 5 - Intangible Assets, Net - Intangible Assets, Future Amortization Expense (Details) - USD ($) | Mar. 31, 2019 | Dec. 31, 2018 |
2019 | $ 263,101 | |
2020 | 350,801 | |
2021 | 29,233 | |
Total | $ 643,135 | $ 730,835 |
Note 6 - Accounts Payable and_3
Note 6 - Accounts Payable and Accrued Expenses - Accounts Payable and Accrued Expenses (Details) - USD ($) | Mar. 31, 2019 | Dec. 31, 2018 |
Accounts payable | $ 473,266 | $ 895,145 |
Accrued payroll and related costs | 541,369 | 851,530 |
Other accrued expenses | 142,544 | 250,570 |
Accrued interest | 72,913 | 72,913 |
Total accounts payable and accrued expenses | $ 1,230,092 | $ 2,070,158 |
Note 7 - Line of Credit, Note_3
Note 7 - Line of Credit, Notes Payable and Liquidity (Details Textual) - USD ($) | Dec. 31, 2018 | Dec. 27, 2018 | Aug. 31, 2017 | Dec. 05, 2016 | Jun. 30, 2016 | Feb. 29, 2016 | Mar. 18, 2013 | Mar. 31, 2019 | Dec. 31, 2018 | Feb. 03, 2015 | Dec. 18, 2013 |
Line of Credit Facility, Maximum Borrowing Capacity | $ 2,000,000 | $ 5,000,000 | $ 4,000,000 | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 2.00% | ||||||||||
Debt Instrument, Periodic Payment, Interest | $ 9,500 | ||||||||||
Long-term Line of Credit, Total | $ 2,500,000 | ||||||||||
Line of Credit Facility, Interest Rate at Period End | 4.50% | ||||||||||
Class of Warrant or Right, Exercised During Period | (2,800,000) | (4,000,000) | |||||||||
Matures on April 1, 2019 [Member] | Chief Executive Officer and Director Mr. Wit [Member] | |||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||
Debt Instrument, Face Amount | $ 450,000 | ||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 2,000,000 | 1,800,000 | |||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.25 | $ 0.25 | |||||||||
Extinguishment of Debt, Amount | $ 400,000 | $ 450,000 | |||||||||
Warrants Sold During the Period | 1,000,000 | ||||||||||
Repayments of Long-term Debt, Total | 50,000 | ||||||||||
Warrants and Rights Exercised | $ 400,000 | ||||||||||
Class of Warrant or Right, Exercised During Period | 1,600,000 | ||||||||||
Warrants and Rights Outstanding | 325,689 | ||||||||||
Debt Instrument, Fair Value Disclosure, Total | $ 124,311 | ||||||||||
Amortization Period of Warrant Liabilities | 3 years 30 days | ||||||||||
Matures April 1, 2020 I [Member] | Investor [Member] | |||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||
Debt Instrument, Face Amount | $ 372,500 | ||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 1,490,000 | ||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.25 | ||||||||||
Repayments of Long-term Debt, Total | $ 145,000 | $ 90,000 | |||||||||
Warrants and Rights Outstanding | $ 246,921 | ||||||||||
Debt Instrument, Fair Value Disclosure, Total | $ 125,579 | ||||||||||
Amortization Period of Warrant Liabilities | 3 years 270 days | ||||||||||
Matures April 1, 2020 II [Member] | Investor [Member] | |||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | ||||||||||
Debt Instrument, Face Amount | $ 420,000 | ||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 1,680,000 | ||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.25 | ||||||||||
Warrants and Rights Outstanding | $ 278,408 | ||||||||||
Debt Instrument, Fair Value Disclosure, Total | $ 141,592 | ||||||||||
Amortization Period of Warrant Liabilities | 3 years 270 days |
Note 7 - Line of Credit, Note_4
Note 7 - Line of Credit, Notes Payable and Liquidity - Notes Payable (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2019 | Dec. 31, 2018 | Mar. 18, 2013 | |
Debt Instrument, Interest Rate, Stated Percentage | 2.00% | ||
Ending principal | $ 557,500 | $ 557,500 | |
Discount on notes payable | |||
Short-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 0 | 0 | |
Discount on notes payable | 0 | 0 | |
Short-term Debt [Member] | Related Party [Member] | |||
Ending principal | 0 | 0 | |
Discount on notes payable | 0 | 0 | |
Long-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 458,952 | 434,316 | |
Discount on notes payable | (98,548) | (123,184) | |
Long-term Debt [Member] | Related Party [Member] | |||
Ending principal | 0 | 0 | |
Discount on notes payable | $ 0 | $ 0 | |
Notes Payable, Matures April 1, 2020 I [Member] | |||
Maturity date | Apr. 1, 2020 | Apr. 1, 2020 | |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | 10.00% | |
Ending principal | $ 420,000 | $ 420,000 | |
Notes Payable, Matures April 1, 2020 I [Member] | Short-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 0 | 0 | |
Notes Payable, Matures April 1, 2020 I [Member] | Short-term Debt [Member] | Related Party [Member] | |||
Ending principal | 0 | 0 | |
Notes Payable, Matures April 1, 2020 I [Member] | Long-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 420,000 | 420,000 | |
Notes Payable, Matures April 1, 2020 I [Member] | Long-term Debt [Member] | Related Party [Member] | |||
Ending principal | $ 0 | $ 0 | |
Notes Payable, Matures April 1, 2020 II [Member] | |||
Maturity date | Apr. 1, 2020 | Apr. 1, 2020 | |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | 12.00% | |
Ending principal | $ 137,500 | $ 137,500 | |
Notes Payable, Matures April 1, 2020 II [Member] | Short-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 0 | 0 | |
Notes Payable, Matures April 1, 2020 II [Member] | Short-term Debt [Member] | Related Party [Member] | |||
Ending principal | 0 | 0 | |
Notes Payable, Matures April 1, 2020 II [Member] | Long-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 137,500 | 137,500 | |
Notes Payable, Matures April 1, 2020 II [Member] | Long-term Debt [Member] | Related Party [Member] | |||
Ending principal | $ 0 | $ 0 |
Note 8 - Convertible Notes Pa_3
Note 8 - Convertible Notes Payable (Details Textual) - USD ($) | Dec. 27, 2018 | Sep. 30, 2018 | Jun. 30, 2018 | Aug. 31, 2017 | Dec. 14, 2016 | Nov. 19, 2015 | May 01, 2015 | Dec. 31, 1999 | Aug. 29, 2008 | Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2018 | Jun. 30, 2017 | Jun. 30, 2016 | Feb. 29, 2016 | Jun. 30, 2015 | May 07, 2015 | Apr. 30, 2015 | Apr. 27, 2015 | Jan. 31, 2015 | Jul. 31, 2014 | Apr. 28, 2014 | Apr. 21, 2014 | Dec. 31, 2013 | Mar. 18, 2013 | Mar. 12, 2013 | Mar. 06, 2013 | Feb. 27, 2013 | Feb. 22, 2013 | Sep. 30, 2009 | Dec. 16, 2008 | Jun. 30, 2008 | Jun. 30, 2004 |
Debt Instrument, Interest Rate, Stated Percentage | 2.00% | ||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 5,970,000 | $ 5,970,000 | |||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.50 | ||||||||||||||||||||||||||||||||
Interest Paid, Excluding Capitalized Interest, Operating Activities | $ 245,256 | $ 254,092 | |||||||||||||||||||||||||||||||
Chief Executive Officer [Member] | |||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 2,000,000 | 1,800,000 | |||||||||||||||||||||||||||||||
Extinguishment of Debt, Amount | $ 400,000 | ||||||||||||||||||||||||||||||||
Convertible Notes 10% [Member] | |||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | ||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 862,500 | ||||||||||||||||||||||||||||||||
Payments of Debt Issuance Costs | 119,625 | ||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 742,875 | ||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 1.25 | ||||||||||||||||||||||||||||||||
Repayments of Convertible Debt | $ 50,000 | ||||||||||||||||||||||||||||||||
Interest Paid, Excluding Capitalized Interest, Operating Activities | $ 96,949 | ||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 862,500 | ||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 1,495,179 | ||||||||||||||||||||||||||||||||
Long-term Debt, Gross | $ 0 | ||||||||||||||||||||||||||||||||
Convertible Debentures Issued August 2008 [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 2,270,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures Issued August 2008 [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member] | |||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | ||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.50 | ||||||||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 4,540,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures Issued August 2008 [Member] | Mr. van Kesteren and Mr. Wit [Member] | Extended Maturity Debentures [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 150,000 | $ 1,920,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued August 2008 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 1,770,000 | 1,770,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued August 2008 [Member] | Director Mr. van Kesteren [Member] | Non-Related Party [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 150,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures Issued August 2008 [Member] | Director Mr. van Kesteren [Member] | Extended Maturity Debentures 2 [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 150,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 150,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 510,000 | ||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 510,000 | ||||||||||||||||||||||||||||||||
Matures April 1, 2020 I [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 4,055,000 | ||||||||||||||||||||||||||||||||
Repayments of Convertible Debt | $ 55,000 | ||||||||||||||||||||||||||||||||
Matures April 1, 2020 I [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures 2 [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | 1,770,000 | ||||||||||||||||||||||||||||||||
Notes Payable, Matures April 1, 2018 [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | 160,000 | ||||||||||||||||||||||||||||||||
Repayments of Convertible Debt | $ 160,000 | ||||||||||||||||||||||||||||||||
Notes Payable, Matures April 1, 2018 [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member] | Extended Maturity Debentures 2 [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | 150,000 | ||||||||||||||||||||||||||||||||
Matures on April 1, 2019 [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member] | Extended Maturity Debentures 2 [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 150,000 | ||||||||||||||||||||||||||||||||
Repayments of Convertible Debt | $ 150,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 5,075,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Non-Related Party [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 160,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Extended Maturity Debentures [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 360,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 1,680,000 | ||||||||||||||||||||||||||||||||
Extinguishment of Debt, Amount | $ 420,000 | ||||||||||||||||||||||||||||||||
Class of Warrant or Right Cancelled During the Period | 1,680,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 4,475,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Director Mr. van Kesteren [Member] | Extended Maturity Debentures [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 160,000 | $ 160,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Chief Executive Officer, Director, Chief Operating Officer, Chairman, Chief Technology Officer, Chief Financial Officer and Directors [Member] | |||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.50 | ||||||||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 10,150,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Officers, Directors and Affiliate [Member] | Extended Maturity Debentures [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 4,980,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Lenders [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 100,000 | $ 200,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Lenders [Member] | Extended Maturity Debentures [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 100,000 | $ 100,000 | $ 200,000 | 4,505,000 | |||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Chief Executive Officer [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | 4,475,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Chief Operating Officer [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | 25,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Chairman and Chief Technology Officer [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 5,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Former Director [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 15,000 | ||||||||||||||||||||||||||||||||
Repayments of Convertible Debt | $ 15,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Former Director [Member] | Extended Maturity Debentures [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 15,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | President [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 25,000 | ||||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Chief Financial Officer [Member] | |||||||||||||||||||||||||||||||||
Repayments of Related Party Debt | $ 5,000 | ||||||||||||||||||||||||||||||||
Matures April 1, 2020 II [Member] | Lenders [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 100,000 | ||||||||||||||||||||||||||||||||
Repayments of Debt | $ 100,000 | ||||||||||||||||||||||||||||||||
Matures April 2021 [Member] | Lenders [Member] | |||||||||||||||||||||||||||||||||
Convertible Notes Payable, Total | $ 200,000 |
Note 8 - Convertible Notes Pa_4
Note 8 - Convertible Notes Payable - Convertible Debt (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2019 | Dec. 31, 2018 | Mar. 18, 2013 | |
Debt Instrument, Interest Rate, Stated Percentage | 2.00% | ||
Convertible Notes Payable, Total | $ 5,970,000 | $ 5,970,000 | |
Convertible notes payable, related parties, long term | 5,770,000 | 5,770,000 | |
Convertible notes payable, long term | 200,000 | 200,000 | |
Related Party [Member] | |||
Convertible notes payable, short term | 0 | 0 | |
Convertible notes payable, related parties, long term | 5,770,000 | 5,770,000 | |
Non-Related Party [Member] | |||
Convertible notes payable, short term | 0 | 0 | |
Convertible notes payable, long term | $ 200,000 | $ 200,000 | |
Convertible Notes Payable 10% $150,000 [Member] | |||
Maturity date | Apr. 1, 2020 | Apr. 1, 2020 | |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | 10.00% | |
Convertible Notes Payable, Total | $ 1,770,000 | $ 1,770,000 | |
Convertible Notes Payable 10% $150,000 [Member] | Related Party [Member] | |||
Convertible notes payable, short term | 0 | 0 | |
Convertible notes payable, related parties, long term | 1,770,000 | 1,770,000 | |
Convertible Notes Payable 10% $150,000 [Member] | Non-Related Party [Member] | |||
Convertible notes payable, short term | 0 | 0 | |
Convertible notes payable, long term | $ 0 | $ 0 | |
Convertible Notes Payable12 Percent, 200,000 [Member] | |||
Maturity date | Apr. 1, 2020 | Apr. 1, 2020 | |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | 12.00% | |
Convertible Notes Payable, Total | $ 4,000,000 | $ 4,000,000 | |
Convertible Notes Payable12 Percent, 200,000 [Member] | Related Party [Member] | |||
Convertible notes payable, short term | 0 | 0 | |
Convertible notes payable, related parties, long term | 4,000,000 | 4,000,000 | |
Convertible Notes Payable12 Percent, 200,000 [Member] | Non-Related Party [Member] | |||
Convertible notes payable, short term | 0 | 0 | |
Convertible notes payable, long term | $ 0 | $ 0 | |
Convertible Notes Payable 12 Percent,100,000 [Member] | |||
Maturity date | Apr. 1, 2021 | Apr. 1, 2021 | |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | 12.00% | |
Convertible Notes Payable, Total | $ 200,000 | $ 200,000 | |
Convertible Notes Payable 12 Percent,100,000 [Member] | Related Party [Member] | |||
Convertible notes payable, short term | 0 | 0 | |
Convertible notes payable, related parties, long term | 0 | 0 | |
Convertible Notes Payable 12 Percent,100,000 [Member] | Non-Related Party [Member] | |||
Convertible notes payable, short term | 0 | 0 | |
Convertible notes payable, long term | $ 200,000 | $ 200,000 |
Note 8 - Convertible Notes Pa_5
Note 8 - Convertible Notes Payable - Convertible Debt Maturity Payments (Details) - USD ($) | Mar. 31, 2019 | Dec. 31, 2018 |
Total | $ 5,970,000 | $ 5,970,000 |
Convertible Debt [Member] | ||
2019 | 0 | |
2020 | 5,770,000 | |
2021 | 200,000 | |
Total | $ 5,970,000 |
Note 9 - Fair Value Measureme_3
Note 9 - Fair Value Measurement (Details Textual) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Jun. 30, 2018 | |
Impairment of Intangible Assets, Finite-lived | $ 79,634 | |
Minimum [Member] | ||
Finite-Lived Intangible Asset, Useful Life | 3 years | |
Maximum [Member] | ||
Finite-Lived Intangible Asset, Useful Life | 15 years |
Note 9 - Fair Value Measureme_4
Note 9 - Fair Value Measurement - Fair Value of Liabilities Measured on a Recurring Basis (Details) - Fair Value, Recurring [Member] - USD ($) | Mar. 31, 2019 | [2] | Dec. 31, 2018 | [3] | |
Derivative Liability fair value | [1] | $ 2,512,114 | $ 1,995,238 | ||
Fair Value, Inputs, Level 1 [Member] | |||||
Derivative Liability fair value | [1] | 0 | 0 | ||
Fair Value, Inputs, Level 2 [Member] | |||||
Derivative Liability fair value | [1] | 0 | 0 | ||
Fair Value, Inputs, Level 3 [Member] | |||||
Derivative Liability fair value | [1] | 2,512,114 | 1,995,238 | ||
Conversion Feature Liability [Member] | |||||
Derivative Liability fair value | [1] | 907,498 | 706,339 | ||
Conversion Feature Liability [Member] | Fair Value, Inputs, Level 1 [Member] | |||||
Derivative Liability fair value | [1] | 0 | 0 | ||
Conversion Feature Liability [Member] | Fair Value, Inputs, Level 2 [Member] | |||||
Derivative Liability fair value | [1] | 0 | 0 | ||
Conversion Feature Liability [Member] | Fair Value, Inputs, Level 3 [Member] | |||||
Derivative Liability fair value | [1] | 907,498 | 706,339 | ||
Warrant Liability [Member] | |||||
Derivative Liability fair value | [1] | 1,604,616 | 1,288,899 | ||
Warrant Liability [Member] | Fair Value, Inputs, Level 1 [Member] | |||||
Derivative Liability fair value | [1] | 0 | 0 | ||
Warrant Liability [Member] | Fair Value, Inputs, Level 2 [Member] | |||||
Derivative Liability fair value | [1] | 0 | 0 | ||
Warrant Liability [Member] | Fair Value, Inputs, Level 3 [Member] | |||||
Derivative Liability fair value | [1] | $ 1,604,616 | $ 1,288,899 | ||
[1] | The fair value at the measurement date is equal to the carrying value on the balance sheet. | ||||
[2] | The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with the following assumptions for the period ended March 31, 2019. | ||||
[3] | The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with the following assumptions for the year ended December 31, 2018. |
Note 9 - Fair Value Measureme_5
Note 9 - Fair Value Measurement - Fair Value Assumptions (Details) | Mar. 31, 2019 | Dec. 31, 2018 |
Measurement Input, Expected Dividend Rate [Member] | ||
Risk free interest rate | 0 | 0 |
Minimum [Member] | Measurement Input, Risk Free Interest Rate [Member] | ||
Risk free interest rate | 0.0255 | 0.027 |
Minimum [Member] | Measurement Input, Price Volatility [Member] | ||
Risk free interest rate | 0.884 | 0.922 |
Minimum [Member] | Measurement Input, Expected Term [Member] | Conversion Feature Liability [Member] | ||
Risk free interest rate | 1.01 | 1.25 |
Minimum [Member] | Measurement Input, Expected Term [Member] | Warrant Liability [Member] | ||
Risk free interest rate | 0 | 0 |
Maximum [Member] | Measurement Input, Risk Free Interest Rate [Member] | ||
Risk free interest rate | 0.0255 | 0.027 |
Maximum [Member] | Measurement Input, Price Volatility [Member] | ||
Risk free interest rate | 0.954 | 0.97 |
Maximum [Member] | Measurement Input, Expected Term [Member] | Conversion Feature Liability [Member] | ||
Risk free interest rate | 2.01 | 2.25 |
Maximum [Member] | Measurement Input, Expected Term [Member] | Warrant Liability [Member] | ||
Risk free interest rate | 2.01 | 2.25 |
Note 9 - Fair Value Measureme_6
Note 9 - Fair Value Measurement - Fair Value of Assets Acquired on Non-recurring Basis (Details) - Fair Value, Nonrecurring [Member] - USD ($) | Mar. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | |||
Reported Value Measurement [Member] | ||||||
Acquired assets | [1] | $ 643,135 | $ 730,835 | $ 97,925 | ||
Reported Value Measurement [Member] | Promasys B.V. Customer List [Member] | ||||||
Acquired assets | [1],[3] | 0 | [2] | 0 | 85,786 | |
Reported Value Measurement [Member] | Promasys B.V. Software Code [Member] | ||||||
Acquired assets | [1],[3] | 0 | 0 | 12,139 | ||
Reported Value Measurement [Member] | Acuity Software Code [Member] | ||||||
Acquired assets | 643,135 | [1],[4] | 730,835 | [1],[4] | $ 0 | |
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 1 [Member] | ||||||
Acquired assets | [1] | 0 | 0 | |||
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 2 [Member] | ||||||
Acquired assets | [1] | 0 | 0 | |||
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 3 [Member] | ||||||
Acquired assets | [1] | 1,261,599 | 1,261,599 | |||
Estimate of Fair Value Measurement [Member] | Promasys B.V. Customer List [Member] | Fair Value, Inputs, Level 1 [Member] | ||||||
Acquired assets | [1],[3] | 0 | [2] | 0 | ||
Estimate of Fair Value Measurement [Member] | Promasys B.V. Customer List [Member] | Fair Value, Inputs, Level 2 [Member] | ||||||
Acquired assets | [1],[3] | 0 | [2] | 0 | ||
Estimate of Fair Value Measurement [Member] | Promasys B.V. Customer List [Member] | Fair Value, Inputs, Level 3 [Member] | ||||||
Acquired assets | [1],[3] | 136,253 | [2] | 136,253 | ||
Estimate of Fair Value Measurement [Member] | Promasys B.V. Software Code [Member] | Fair Value, Inputs, Level 1 [Member] | ||||||
Acquired assets | [1],[3] | 0 | 0 | |||
Estimate of Fair Value Measurement [Member] | Promasys B.V. Software Code [Member] | Fair Value, Inputs, Level 2 [Member] | ||||||
Acquired assets | [1],[3] | 0 | 0 | |||
Estimate of Fair Value Measurement [Member] | Promasys B.V. Software Code [Member] | Fair Value, Inputs, Level 3 [Member] | ||||||
Acquired assets | [1],[3] | 72,943 | 72,943 | |||
Estimate of Fair Value Measurement [Member] | Acuity Software Code [Member] | Fair Value, Inputs, Level 1 [Member] | ||||||
Acquired assets | 0 | [1],[4] | 0 | |||
Estimate of Fair Value Measurement [Member] | Acuity Software Code [Member] | Fair Value, Inputs, Level 2 [Member] | ||||||
Acquired assets | 0 | [1],[4] | 0 | |||
Estimate of Fair Value Measurement [Member] | Acuity Software Code [Member] | Fair Value, Inputs, Level 3 [Member] | ||||||
Acquired assets | $ 1,052,403 | [1],[4] | $ 1,052,403 | |||
[1] | The fair value of the acquired assets was estimated using the Income Approach with a discounted cash flow valuation methodology applied. | |||||
[2] | During the second quarter of 2018 we recognized an impairment loss of $79,634 on the Promasys B.V. Customer List after performing a fair value analysis on the asset utilizing a discounted cash flow model. The impairment charge is separately presented on the Statement of Operations. | |||||
[3] | The acquired Promasys B.V. software code and customer list are not measured on a recurring basis since their initial fair value has been deemed to have a finite life and is being amortized periodically. Instead, the Company performs an impairment analysis on a quarterly basis in order to determine whether the carrying value of the assets reflects the fair value of the assets in a market based transaction. | |||||
[4] | The acquired Acuity software code is not measured on a recurring basis since the initial fair value has been deemed to have a finite life and is being amortized periodically. Instead, the Company performs an impairment analysis on a quarterly basis in order to determine whether the carrying value of the assets reflects the fair value of the assets in a market based transaction. |
Note 9 - Fair Value Measureme_7
Note 9 - Fair Value Measurement - Unrealized Gain or Loss Included in Earnings (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
The net amount of gains/(losses) for the period included in earnings attributable to the unrealized and realized gains/(losses) from changes in derivative liabilities at the reporting date | $ (583,657) | $ 28,416 |
Note 9 - Fair Value Measureme_8
Note 9 - Fair Value Measurement - Change in Level 3 Financial Liabilities Fair Value (Details) - USD ($) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2019 | Dec. 31, 2018 | |
Balance, beginning of year | $ (1,995,238) | $ (5,126,746) |
Net realized gains/(losses) | 0 | 0 |
Net unrealized gains/(losses) relating to instruments still held at the reporting date | (583,657) | 3,111,760 |
Net purchases, issuances and settlements | 66,781 | 9,248 |
Net transfers in and/or out of Level 3 | 0 | 10,500 |
Balance, end of period | (2,512,114) | (1,995,238) |
Conversion Feature Liability [Member] | ||
Balance, beginning of year | (706,339) | (1,685,947) |
Net realized gains/(losses) | 0 | 0 |
Net unrealized gains/(losses) relating to instruments still held at the reporting date | (201,159) | 969,108 |
Net purchases, issuances and settlements | 0 | 0 |
Net transfers in and/or out of Level 3 | 0 | 10,500 |
Balance, end of period | (907,498) | (706,339) |
Warrant Liability [Member] | ||
Balance, beginning of year | (1,288,899) | (3,440,799) |
Net realized gains/(losses) | 0 | 0 |
Net unrealized gains/(losses) relating to instruments still held at the reporting date | (382,498) | 2,142,652 |
Net purchases, issuances and settlements | 66,781 | 9,248 |
Net transfers in and/or out of Level 3 | 0 | 0 |
Balance, end of period | $ (1,604,616) | $ (1,288,899) |
Note 10 - Leases (Details Textu
Note 10 - Leases (Details Textual) - USD ($) | 3 Months Ended | |||
Mar. 31, 2019 | Mar. 31, 2018 | Jan. 01, 2019 | Dec. 31, 2018 | |
Operating Lease, Right-of-Use Asset | $ 1,569,465 | $ 0 | ||
Operating Lease, Expense | 311,799 | $ 289,334 | ||
Finance Lease, Right-of-Use Asset, Amortization | 32,683 | |||
Operating Lease, Liability, Total | $ 1,569,465 | |||
Accounting Standards Update 2016-02 [Member] | ||||
Operating Lease, Right-of-Use Asset | $ 1,729,630 | |||
Operating Lease, Liability, Total | $ 1,730,907 |
Note 10 - Leases - Lease Inform
Note 10 - Leases - Lease Information (Details) - USD ($) | 3 Months Ended | ||
Mar. 31, 2019 | Dec. 31, 2018 | ||
Right-of-use assets | $ 1,569,465 | $ 0 | |
Current lease liability | 598,108 | 0 | |
Non-current lease liability | 971,357 | $ 0 | |
Total lease liabilities | $ 1,569,465 | ||
Operating leases. weighted-average remaining lease term (Year) | 3 years 109 days | ||
Finance leases, weighted-average remaining lease term (Year) | 2 years 43 days | ||
Operating leases, discount rate | 4.50% | ||
Finance leases, discount rate | 6.94% | ||
Operating lease cost | $ 167,888 | ||
Variable lease cost (1) | [1] | 140,910 | |
Total lease cost | 308,798 | ||
Cash paid for operating lease cost | 167,942 | ||
Operating lease assets obtained in exchange for operating lease liabilities | $ 1,729,630 | ||
[1] | Variable lease cost primarily relates to common area maintenance, property taxes and insurance on leased real estate |
Note 10 - Leases - Minimum Leas
Note 10 - Leases - Minimum Lease Payments (Details) | Mar. 31, 2019USD ($) |
2019, operating leases | $ 468,042 |
2020, operating leases | 476,293 |
2021, operating leases | 340,478 |
2022, operating leases | 340,746 |
Thereafter, operating leases | 76,446 |
Total undiscounted lease payments, operating leases | 1,702,005 |
Less: amount representing interest | (132,540) |
Present value of lease payments, operating leases | 1,569,465 |
2019, finance leases | 97,552 |
2020, finance leases | 130,069 |
2021, finance leases | 51,898 |
Total minimum finance lease payments, finance leases | 279,519 |
Less: Amount representing interest, finance leases | (19,034) |
Present value of minimum finance lease payments, finance leases | $ 260,485 |
Note 10 - Leases - Future Minim
Note 10 - Leases - Future Minimum Lease Payments (Details) | Dec. 31, 2018USD ($) |
2019 | $ 655,901 |
2020 | 414,973 |
2021 | 340,029 |
2022 | 340,270 |
Thereafter | 76,243 |
Total | $ 1,827,416 |
Note 12 - Related Party Trans_2
Note 12 - Related Party Transactions (Details Textual) - USD ($) | Dec. 27, 2018 | Aug. 31, 2017 | Nov. 19, 2015 | Mar. 18, 2013 | Dec. 16, 2008 | Aug. 29, 2008 | Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2018 | Jun. 30, 2016 | Feb. 29, 2016 | Feb. 03, 2015 | Jan. 31, 2015 | Dec. 31, 2013 | Dec. 18, 2013 | Feb. 22, 2013 | Oct. 16, 2012 | Sep. 30, 2009 | Jun. 30, 2008 | Feb. 29, 2008 |
Convertible Notes Payable, Total | $ 5,970,000 | $ 5,970,000 | ||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 2.00% | |||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.50 | |||||||||||||||||||
Class of Warrant or Right, Exercised During Period | (2,800,000) | (4,000,000) | ||||||||||||||||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 2,000,000 | $ 5,000,000 | $ 4,000,000 | |||||||||||||||||
Long-term Line of Credit, Total | $ 2,500,000 | |||||||||||||||||||
Line of Credit Facility, Interest Rate at Period End | 4.50% | |||||||||||||||||||
Interest Expense, Related Party | $ 190,109 | $ 225,418 | ||||||||||||||||||
The Northern Trust Company [Member] | ||||||||||||||||||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 2,000,000 | $ 5,000,000 | $ 4,000,000 | |||||||||||||||||
Line of Credit Facility, Interest Rate During Period | 2.00% | |||||||||||||||||||
Long-term Line of Credit, Total | $ 2,500,000 | |||||||||||||||||||
Line of Credit Facility, Interest Rate at Period End | 4.50% | |||||||||||||||||||
Director Mr. Wit [Member] | ||||||||||||||||||||
Interest Expense, Related Party Approximately Monthly Amount | $ 9,500 | |||||||||||||||||||
Chief Executive Officer [Member] | ||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 2,000,000 | 1,800,000 | ||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |||||||||||||||||||
Notes Payable, Related Parties | $ 450,000 | |||||||||||||||||||
Extinguishment of Debt, Amount | $ 400,000 | |||||||||||||||||||
Repayments of Notes Payable | $ 50,000 | |||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.25 | $ 0.25 | ||||||||||||||||||
Interest Payable | $ 450,000 | |||||||||||||||||||
Warrants and Rights Exercised | $ 400,000 | |||||||||||||||||||
Class of Warrant or Right, Exercised During Period | 1,600,000 | |||||||||||||||||||
Convertible Debentures [Member] | Director Mr. Wit [Member] | ||||||||||||||||||||
Due to Related Parties, Total | $ 5,770,000 | |||||||||||||||||||
Convertible Notes Payable, Total | $ 510,000 | |||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 510,000 | |||||||||||||||||||
Convertible Debenture Initiated In June 2008 [Member] | Director Mr. Wit [Member] | ||||||||||||||||||||
Convertible Notes Payable, Total | $ 1,260,000 | $ 1,770,000 | $ 1,770,000 | $ 1,770,000 | $ 1,770,000 | |||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 3,540,000 | |||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | |||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.50 | |||||||||||||||||||
Convertible Debenture Initiated In February 2008 [Member] | Director Mr. Wit [Member] | ||||||||||||||||||||
Convertible Notes Payable, Total | 4,475,000 | 4,475,000 | $ 125,000 | $ 4,350,000 | $ 4,200,000 | |||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 4,350,000 | |||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 1,680,000 | 8,700,000 | 250,000 | |||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.50 | |||||||||||||||||||
Notes Payable, Related Parties | $ 150,000 | |||||||||||||||||||
Debt Conversion, Converted Instrument, Rate | 12.00% | |||||||||||||||||||
Extinguishment of Debt, Amount | $ 420,000 | |||||||||||||||||||
Class of Warrant or Right Cancelled During the Period | 1,680,000 | |||||||||||||||||||
Convertible Debenture Initiated In February 2008 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member] | ||||||||||||||||||||
Convertible Notes Payable, Total | $ 4,055,000 | |||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | ||||||||||||||||||||
Convertible Notes Payable, Total | $ 5,075,000 | |||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Extended Maturity Debentures [Member] | ||||||||||||||||||||
Convertible Notes Payable, Total | $ 360,000 | |||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Director Mr. Wit [Member] | ||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 1,680,000 | |||||||||||||||||||
Extinguishment of Debt, Amount | $ 420,000 | |||||||||||||||||||
Class of Warrant or Right Cancelled During the Period | 1,680,000 | |||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member] | ||||||||||||||||||||
Convertible Notes Payable, Total | $ 4,475,000 | |||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Chief Executive Officer and Director Mr. Wit [Member] | ||||||||||||||||||||
Repayments of Notes Payable | $ 55,000 | |||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Chief Executive Officer [Member] | ||||||||||||||||||||
Convertible Notes Payable, Total | $ 4,475,000 |
Note 13 - Stockholders' (Defi_3
Note 13 - Stockholders' (Deficit) (Details Textual) | Mar. 21, 2019$ / sharesshares | Mar. 14, 2019USD ($)$ / sharesshares | Mar. 04, 2019USD ($)$ / sharesshares | Jan. 01, 2019USD ($)$ / sharesshares | Sep. 06, 2018USD ($)$ / sharesshares | Mar. 31, 2019USD ($)$ / sharesshares | Dec. 31, 2018$ / sharesshares | Mar. 31, 2018shares | Dec. 31, 2017shares |
Common Stock, Shares Authorized | 500,000,000 | 500,000,000 | |||||||
Common Stock, Par or Stated Value Per Share | $ / shares | $ 0.001 | $ 0.001 | |||||||
Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | |||||||
Preferred Stock, Par or Stated Value Per Share | $ / shares | $ 0.001 | $ 0.001 | |||||||
Common Stock, Shares, Issued, Total | 158,278,341 | 155,368,647 | |||||||
Class of Warrant or Right, Issued | 19,020,000 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Issued, Number | 2,420,000 | ||||||||
Convertible Debt, Total | $ | $ 5,970,000 | ||||||||
Debt Instrument, Convertible, Number of Equity Instruments | 115,677 | ||||||||
Class of Warrant or Right, Exercised During Period | (2,800,000) | (4,000,000) | |||||||
Common Stock, Shares, Outstanding, Ending Balance | 158,278,341 | 155,368,647 | |||||||
Class of Warrant or Right, Outstanding | 19,020,000 | 22,020,000 | 27,020,000 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance | 2,420,000 | 2,570,000 | 5,275,000 | ||||||
Restricted Stock [Member] | |||||||||
Common Stock, Shares, Outstanding, Ending Balance | 1,825,000 | 0 | |||||||
Executive Vice Chairman [Member] | |||||||||
Stock Issued During Period, Shares, New Issues | 1,800,000 | ||||||||
Class of Warrant or Right, Exercised During Period | 1,800,000 | ||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 0.25 | ||||||||
Proceeds from Warrant Exercises | $ | $ 450,000 | ||||||||
Chief Executive Officer, Chief Financial Officer, Chief Operating Officer and Chief Technology Officer [Member] | Restricted Stock [Member] | RSAs [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant For Each Recipient | 225,000 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Subject to Individual Performance | 75,000 | 75,000 | |||||||
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issuable upon Milestones Achieved | 75,000 | 75,000 | 75,000 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Minimum Revenues to be Recognized | $ | $ 32,500,000 | $ 32,500,000 | $ 30,000,000 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Minimum EBITDA to be Recognized | $ | $ 6,500,000 | $ 6,500,000 | $ 6,000,000 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Issuable upon Milestones Achieved | 75,000 | 75,000 | 75,000 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Minimum Revenues to be Recognized for Additional Shares | $ | $ 33,900,000 | $ 33,900,000 | $ 32,000,000 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Minimum EBITDA to be Recognized for Additional Shares | $ | $ 6,800,000 | $ 6,800,000 | $ 7,000,000 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance | $ / shares | $ 0.28 | $ 0.28 | $ 0.33 | ||||||
Employee [Member] | |||||||||
Stock Issued During Period, Shares, New Issues | 209,694 | ||||||||
Class of Warrant or Right, Exercised During Period | 1,000,000 | ||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 0.25 | ||||||||
Conversion of Conversion Debt into Common Stock [Member] | |||||||||
Debt Instrument, Convertible, Number of Equity Instruments | 11,940,000 | ||||||||
Convertible Debt [Member] | |||||||||
Interest Payable | $ | $ 57,838 | ||||||||
Series A Preferred Stock [Member] | |||||||||
Preferred Stock, Shares Authorized | 5,000,000 | 5,000,000 | |||||||
Preferred Stock, Par or Stated Value Per Share | $ / shares | $ 0.001 | $ 0.001 | |||||||
Preferred Stock, Dividend Rate, Percentage | 5.00% | ||||||||
Preferred Stock, Shares Outstanding, Ending Balance | 0 | 0 | |||||||
Preferred Stock, Shares Issued, Total | 0 | 0 | |||||||
Series B Preferred Stock [Member] | |||||||||
Preferred Stock, Shares Authorized | 230,000 | 230,000 | |||||||
Preferred Stock, Par or Stated Value Per Share | $ / shares | $ 0.001 | $ 0.001 | |||||||
Preferred Stock, Shares Outstanding, Ending Balance | 0 | 0 | |||||||
Preferred Stock, Shares Issued, Total | 0 | 0 | |||||||
Series C Preferred Stock [Member] | |||||||||
Preferred Stock, Shares Authorized | 747,500 | 747,500 | |||||||
Preferred Stock, Par or Stated Value Per Share | $ / shares | $ 0.001 | $ 0.001 | |||||||
Preferred Stock, Shares Outstanding, Ending Balance | 0 | 0 | |||||||
Preferred Stock, Shares Issued, Total | 0 | 0 | |||||||
Series D Preferred Stock [Member] | |||||||||
Preferred Stock, Shares Authorized | 250,000 | 250,000 | |||||||
Preferred Stock, Par or Stated Value Per Share | $ / shares | $ 0.001 | $ 0.001 | |||||||
Preferred Stock, Shares Outstanding, Ending Balance | 250,000 | 250,000 | |||||||
Preferred Stock, Shares Issued, Total | 250,000 | 250,000 |
Note 13 - Stockholders' (Defi_4
Note 13 - Stockholders' (Deficit) - Cumulative Arrearage of Undeclared Dividends (Details) - USD ($) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2019 | Dec. 31, 2018 | |
Preferred Stock, Dividend, Cumulative Arrearage | $ 2,081,980 | $ 2,081,980 |
Preferred Stock, Dividend, Cumulative Arrearage Per Share (in dollars per share) | ||
Series B Preferred Stock [Member] | ||
Preferred Stock, Dividend, Cumulative Arrearage | $ 609,887 | $ 609,887 |
Preferred Stock, Dividend, Cumulative Arrearage Per Share (in dollars per share) | $ 3.05 | $ 3.05 |
Series C Preferred Stock [Member] | ||
Preferred Stock, Dividend, Cumulative Arrearage | $ 1,472,093 | $ 1,472,093 |
Preferred Stock, Dividend, Cumulative Arrearage Per Share (in dollars per share) | $ 4.37 | $ 4.37 |
Note 13 - Stockholders' (Defi_5
Note 13 - Stockholders' (Deficit) - Warrants (Details) - $ / shares | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | |
Number outstanding (in shares) | 19,020,000 | 22,020,000 | 27,020,000 |
Weighted average remaining contractual life (Year) | 354 days | 1 year 21 days | |
Weighted average exercise price (in dollars per share) | $ 0.48 | $ 0.45 | |
Class of Warrant or Right, Exercisable (in shares) | 19,020,000 | 22,020,000 | |
Warrants exercisable, weighted average exercise price (in dollars per share) | $ 0.48 | $ 0.45 | |
Minimum [Member] | |||
Range of exercise price (in dollars per share) | 0.25 | 0.25 | |
Maximum [Member] | |||
Range of exercise price (in dollars per share) | $ 0.60 | $ 0.60 |
Note 13 - Stockholders' (Defi_6
Note 13 - Stockholders' (Deficit) - Warrants Activity (Details) - shares | 3 Months Ended | 12 Months Ended |
Mar. 31, 2019 | Dec. 31, 2018 | |
Balance (in shares) | 22,020,000 | 27,020,000 |
Issued (in shares) | 0 | 0 |
Class of Warrant or Right, Exercised During Period | (2,800,000) | (4,000,000) |
Expired/forfeited (in shares) | (200,000) | (1,000,000) |
Balance (in shares) | 19,020,000 | 22,020,000 |
Warrants exercisable at March 31, 2019 (in shares) | 19,020,000 | 22,020,000 |
Note 13 - Stockholders' (Defi_7
Note 13 - Stockholders' (Deficit) - Accumulated Other Comprehensive Gain (Loss) (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2019 | Dec. 31, 2018 | |
Balance | $ (11,683,904) | $ (17,193,058) |
Balance | (11,683,904) | |
Accumulated Foreign Currency Adjustment Attributable to Parent [Member] | ||
Balance | (436,505) | (397,237) |
Activity | (5,430) | (39,268) |
Balance | (441,935) | (436,505) |
AOCI Attributable to Parent [Member] | ||
Balance | (436,505) | (397,237) |
Activity | (5,430) | (39,268) |
Balance | $ (441,935) | $ (436,505) |
Note 14 - Equity Incentive Pl_3
Note 14 - Equity Incentive Plans (Details Textual) - USD ($) | Mar. 14, 2019 | Mar. 04, 2019 | Dec. 31, 2018 | Sep. 06, 2018 | Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2018 | Dec. 31, 2017 | Jun. 16, 2016 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance | 2,570,000 | 2,420,000 | 2,570,000 | 5,275,000 | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 0 | 300,000 | |||||||
Proceeds from Stock Options Exercised | $ 0 | $ 0 | |||||||
Share-based Payment Arrangement, Expense, Tax Benefit | $ 0 | $ 0 | |||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 0 | $ 0.23 | |||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 0 | 570,000 | |||||||
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | $ 195,598 | ||||||||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition | 1 year 328 days | ||||||||
Restricted Stock [Member] | |||||||||
Share-based Payment Arrangement, Expense | $ 77,610 | ||||||||
Restricted Stock [Member] | Chief Executive Officer [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | 150,000 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | 225,000 | ||||||||
Restricted Stock [Member] | Board of Director One [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | 75,000 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | 200,000 | ||||||||
The 2016 Plan [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 11,576,250 | 10,000,000 | |||||||
Common Stock Available for Issuance Increasing Period | 9 years | ||||||||
Common Stock Available for Issuance, Annual Increase Percent | 5.00% | ||||||||
Common Stock, Capital Shares Reserved for Future Issuance | 11,576,250 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 5 years | ||||||||
Share-based Compensation Arrangement, Restricted Shares Granted to Employees, Number of Installments in Which Restrictions Lapse | 3 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance | 2,245,000 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 100,000 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 7,406,250 | ||||||||
The 2016 Plan [Member] | Share-based Payment Arrangement, Tranche One [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 50.00% | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period | 1 year | ||||||||
The 2016 Plan [Member] | Share-based Payment Arrangement, Option [Member] | |||||||||
Share-based Compensation Arrangement, Installments for Vesting | 2 | ||||||||
The 2016 Plan [Member] | Restricted Stock [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance | 1,825,000 | ||||||||
The 2016 Plan [Member] | Maximum [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 10 years | ||||||||
RSAs [Member] | Restricted Stock [Member] | Chief Executive Officer, Chief Financial Officer, Chief Operating Officer and Chief Technology Officer [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance | $ 0.28 | $ 0.28 | $ 0.33 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant For Each Recipient | 225,000 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Subject to Individual Performance | 75,000 | 75,000 | |||||||
Share-based Compensation Arrangement by Share-based Payment Award, Minimum Revenues to be Recognized | $ 32,500,000 | $ 32,500,000 | $ 30,000,000 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Minimum EBITDA to be Recognized | $ 6,500,000 | $ 6,500,000 | $ 6,000,000 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issuable upon Milestones Achieved | 75,000 | 75,000 | 75,000 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Minimum Revenues to be Recognized for Additional Shares | $ 33,900,000 | $ 33,900,000 | $ 32,000,000 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Minimum EBITDA to be Recognized for Additional Shares | $ 6,800,000 | $ 6,800,000 | $ 7,000,000 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Issuable upon Milestones Achieved | 75,000 | 75,000 | 75,000 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 3 years | ||||||||
RSAs [Member] | Restricted Stock [Member] | Director [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance | $ 0.33 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant For Each Recipient | 200,000 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Minimum Revenues to be Recognized | $ 30,000,000 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Minimum EBITDA to be Recognized | $ 6,000,000 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issuable upon Milestones Achieved | 75,000 | ||||||||
RSAs [Member] | Maximum [Member] | Restricted Stock [Member] | Chief Executive Officer, Chief Financial Officer, Chief Operating Officer and Chief Technology Officer [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant For Each Recipient | 225,000 | ||||||||
Equity Incentive Plan 2009 [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 7,500,000 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 5 years | ||||||||
Share-based Compensation Arrangement, Installments for Vesting | 2 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance | 175,000 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 0 | ||||||||
Equity Incentive Plan 2009 [Member] | Share-based Payment Arrangement, Tranche One [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 50.00% | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period | 1 year | ||||||||
Equity Incentive Plan 2009 [Member] | Restricted Stock [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance | 3,876,662 | ||||||||
Equity Incentive Plan 2009 [Member] | Maximum [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 10 years |
Note 14 - Equity Incentive Pl_4
Note 14 - Equity Incentive Plans - Stock Option Activity (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | |
Number of shares (in shares) | 2,570,000 | 5,275,000 | |
Weighted average exercise price (per share) (in dollars per share) | $ 0.28 | $ 0.26 | |
Weighted average remaining contractual term (in years) (Year) | 3 years 73 days | 3 years 171 days | 4 years 32 days |
Aggregate intrinsic value | $ 109,000 | $ 16,675 | $ 130,475 |
Number of shares, granted (in shares) | 0 | 570,000 | |
Weighted average exercise price (per share), granted (in dollars per share) | $ 0 | $ 0.28 | |
Number of shares, exercised (in shares) | 0 | (300,000) | |
Weighted average exercise price (per share), exercised (in dollars per share) | $ 0 | $ 0.21 | |
Number of shares, forfeited/cancelled/expired (in shares) | (150,000) | (2,975,000) | |
Weighted average exercise price (per share), forfeited/cancelled/expired (in dollars per share) | $ 0.25 | $ 0.25 | |
Number of shares (in shares) | 2,420,000 | 2,570,000 | 5,275,000 |
Weighted average exercise price (per share) (in dollars per share) | $ 0.28 | $ 0.28 | $ 0.26 |
Vested and exercisable at March 31, 2019 (in shares) | 1,547,500 | ||
Vested and exercisable at March 31, 2019 (in dollars per share) | $ 0.26 | ||
Vested and exercisable at March 31, 2019 (Year) | 2 years 350 days | ||
Vested and exercisable at March 31, 2019 | $ 94,275 |
Note 14 - Equity Incentive Pl_5
Note 14 - Equity Incentive Plans - Vested Shares (Details) - USD ($) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2019 | Dec. 31, 2018 | |
Number of options vested (in shares) | 660,000 | 500,000 |
Fair value of options vested | $ 136,775 | $ 99,121 |
Note 14 - Equity Incentive Pl_6
Note 14 - Equity Incentive Plans - Stock Options Outstanding (Details) - $ / shares | 3 Months Ended | 12 Months Ended |
Mar. 31, 2019 | Dec. 31, 2018 | |
Low price range (in dollars per share) | $ 0 | $ 0 |
High price range (in dollars per share) | $ 0.50 | $ 0.50 |
Outstanding stock options (in shares) | 2,420,000 | 2,570,000 |
Weighted average remaining contractual life - outstanding (Year) | 3 years 73 days | 3 years 171 days |
Weighted average outstanding strike price - outstanding (in dollars per share) | $ 0.28 | $ 0.28 |
Vested stock options (in shares) | 1,547,500 | 887,500 |
Weighted average remaining contractual life - vested (Year) | 2 years 350 days | 2 years 335 days |
Weighted average outstanding strike price - vested (in dollars per share) | $ 0.26 | $ 0.25 |
Range One [Member] | ||
Low price range (in dollars per share) | 0 | 0 |
High price range (in dollars per share) | $ 0.20 | $ 0.20 |
Outstanding stock options (in shares) | 150,000 | 150,000 |
Weighted average remaining contractual life - outstanding (Year) | 248 days | 339 days |
Weighted average outstanding strike price - outstanding (in dollars per share) | $ 0.17 | $ 0.17 |
Vested stock options (in shares) | 150,000 | 150,000 |
Weighted average remaining contractual life - vested (Year) | 248 days | 339 days |
Weighted average outstanding strike price - vested (in dollars per share) | $ 0.17 | $ 0.17 |
Range Two [Member] | ||
Low price range (in dollars per share) | 0.21 | 0.21 |
High price range (in dollars per share) | $ 0.30 | $ 0.30 |
Outstanding stock options (in shares) | 1,545,000 | 1,695,000 |
Weighted average remaining contractual life - outstanding (Year) | 3 years 102 days | 3 years 197 days |
Weighted average outstanding strike price - outstanding (in dollars per share) | $ 0.26 | $ 0.26 |
Vested stock options (in shares) | 1,210,000 | 550,000 |
Weighted average remaining contractual life - vested (Year) | 3 years 54 days | 3 years 54 days |
Weighted average outstanding strike price - vested (in dollars per share) | $ 0.26 | $ 0.25 |
Range Three [Member] | ||
Low price range (in dollars per share) | 0.31 | 0.31 |
High price range (in dollars per share) | $ 0.50 | $ 0.50 |
Outstanding stock options (in shares) | 725,000 | 725,000 |
Weighted average remaining contractual life - outstanding (Year) | 3 years 208 days | 3 years 299 days |
Weighted average outstanding strike price - outstanding (in dollars per share) | $ 0.34 | $ 0.34 |
Vested stock options (in shares) | 187,500 | 187,500 |
Weighted average remaining contractual life - vested (Year) | 3 years 208 days | 3 years 299 days |
Weighted average outstanding strike price - vested (in dollars per share) | $ 0.34 | $ 0.34 |
Note 14 - Equity Incentive Pl_7
Note 14 - Equity Incentive Plans - Fair Value Assumptions of Share-based Payments (Details) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2019 | Dec. 31, 2018 | |
Risk-free interest rate | 2.48% | 2.91% |
Expected dividend yield | 0.00% | 0.00% |
Expected volatility | 102.60% | 111.00% |
Expected life of options (Year) | 5 years | 5 years |
Note 14 - Equity Incentive Pl_8
Note 14 - Equity Incentive Plans - Weighted Average Grant Date Fair Value Activity (Details) - $ / shares | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Stock options granted during the period (in dollars per share) | $ 0 | $ 0.23 |
Stock options vested during the period (in dollars per share) | 0.21 | 0.20 |
Stock options forfeited during the period (in dollars per share) | $ 0.21 | $ 0.19 |
Note 14 - Equity Incentive Pl_9
Note 14 - Equity Incentive Plans - Status of Non-vested Shares (Details) - $ / shares | Mar. 31, 2019 | Jan. 01, 2019 |
Shares underlying stock options (in shares) | 872,500 | 1,682,500 |
Weighted average grant date fair value (in dollars per share) | $ 0.27 | $ 0.24 |
Note 15 - Subsequent Events (De
Note 15 - Subsequent Events (Details Textual) - USD ($) | Mar. 21, 2019 | Jan. 01, 2019 | May 13, 2019 | Mar. 31, 2019 | Dec. 31, 2018 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 0 | 300,000 | |||
Class of Warrant or Right, Exercised During Period | (2,800,000) | (4,000,000) | |||
Employee [Member] | |||||
Class of Warrant or Right, Exercised During Period | 1,000,000 | ||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.25 | ||||
Executive Vice Chairman [Member] | |||||
Class of Warrant or Right, Exercised During Period | 1,800,000 | ||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.25 | ||||
Subsequent Event [Member] | |||||
Repayments of Lines of Credit | $ 1,400,000 | ||||
Subsequent Event [Member] | Employee [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 50,000 | ||||
Subsequent Event [Member] | Executive Vice Chairman [Member] | |||||
Class of Warrant or Right, Exercised During Period | 800,000 | ||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.25 |